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ABSTRACT OF DISSERTATION 
 
 
 
 
GROUP I INTRON-DERIVED 
RIBOZYME REACTIONS 
 
 
Group I introns are catalytic RNAs capable of self-splicing out of RNA 
transcripts.  Ribozymes derived from these group I introns are used to explore the 
molecular recognition properties involved in intron catalysis.  New ribozyme reactions 
are designed based on the inherent ability of these ribozymes to perform site-specific 
nucleophilic attacks.  This study explores the molecular recognition properties of group I 
intron-derived ribozyme reactions and describe a new ribozyme reaction involving 
molecular recognition properties previously not seen. 
We report the development, analysis, and use of a new combinatorial approach to 
analyze the substrate sequence dependence of suicide inhibition, cyclization, and reverse 
cyclization reactions catalyzed by a group I intron from the opportunistic pathogen 
Pneumocystis carinii. We demonstrate that the sequence specificity of these Internal 
Guide Sequence (IGS) mediated reactions is not high, suggesting that RNA targeting 
strategies which exploit tertiary interactions could have low specificity due to the 
tolerance of mismatched base pairs. 
 A group I intron-derived ribozyme from P. carinii has been previously shown to 
bind an exogenous RNA substrate, splice-out an internal segment, and then ligate the two 
ends back together (the trans excision-splicing reaction).  We now report that a group I 
intron derived ribozyme from the ciliate Tetrahymena thermophila can also perform the 
trans excision-splicing reaction, although not nearly as well as the P. carinii ribozyme.   
In addition, we discovered a new ribozyme reaction called trans insertion-splicing 
where the P. carinii ribozyme binds two exogenous RNA substrates and inserts one 
directly into the other.  Although this reaction gives the reverse products of the trans 
excision-splicing reaction, the trans insertion-splicing reaction is not simply the reverse 
reaction.  The ribozyme recognizes two exogenous substrates through more complex 
molecular recognition interactions than what has been previously seen in group I intron-
derived ribozyme reactions.  We give evidence for this new reaction mechanism 
composed of three steps, with intermediates attached to the ribozyme.   
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CHAPTER ONE - Introduction 
 
Since the discovery of catalytic RNA in the early 1980s (1, 2), the view of RNA 
as simply an intermediary between DNA and proteins has drastically changed.  For 
example, many naturally occurring catalytic RNA reactions have been found (3, 4).  
Ribozymes derived from naturally occurring catalytic RNAs have been developed for use 
as therapeutics (5-9) and biochemical tools (10, 11).  Even more recently, the discovery 
of RNA interference (12, 13) and riboswitches (14, 15)  show that RNA is involved in the 
most basic levels of gene regulation.   
Self-splicing group I introns are catalytic RNAs that splice out of cellular RNA 
transcripts, often without the need for proteins (1).  Group I introns are defined as having 
a conserved secondary structure (a series of base paired helices named P1 through P10) 
and a similar self-splicing mechanism.  The intron positions itself for catalysis by base 
pairing with its exons and forming tertiary interactions.  These complex catalytic 
activities are self-contained within RNAs of relatively moderate size, often less than 400 
nucleotides. Therefore, group I introns are frequently exploited as model systems in the 
continual pursuit of a more thorough understanding of RNA structure and function. As 
the self-splicing reaction is single-turnover, such studies often utilize group I intron-
derived ribozymes, which are introns that lack the endogenous 5’ and 3’ exons (16, 17). 
Ribozymes recognize their substrates (exon mimics) partially through base 
pairing with their internal guide sequence (IGS).  The base paired IGS makes up the P1 
and P10 helices that dock into the catalytic core of the ribozyme (positioned through 
tertiary interactions).  The molecular recognition of the substrate by the ribozyme is 
dependent on these base pairing and tertiary interactions.  Studying these critical 
molecular recognition interactions allows us to better understand the ribozyme and its 
ability to catalyze a reaction.    
 
Combinatorial Approach to Analyze Molecular Recognition in the P. carinii Ribozyme 
The sequence dependence of the 5' exon-IGS interaction has been studied using a 
group I intron-derived ribozyme from the ciliate Tetrahymena thermophila, but the 
sequence dependence of this interaction for a Pneumocystis carinii group I intron-derived 
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ribozyme had not been analyzed before.  Studying the P. carinii ribozyme is of interest 
because previous results have shown that the P. carinii and Tetrahymena ribozymes 
utilize a different array of tertiary interactions to dock the P1 helix into the catalytic core 
(17-19). Also, the P. carinii ribozyme has been shown to catalyze the trans excision-
splicing and the trans insertion-splicing reactions, which have potential applications to 
alter RNA.  The sequence dependence of this molecular recognition interaction for the P. 
carinii ribozyme is therefore of interest.  Reactions based on the self-splicing and 
cyclization reactions of the group I intron were used to study the sequence specificity of 
the P. carinii ribozyme. 
A combinatorial approach, using randomized 5’ exon mimics, allowed us to 
assess the sequence specificity of the P. carinii IGS.  Exogenous 5’ exon mimics can 
bind the IGS of the intron, forming a P1 helix.  If the 5’-exon mimic binds the intron 
before it self-splices, it becomes ligated to the 3’-exon (Figure 3.1, F-G).  This reaction 
disrupts self-splicing and is called suicide inhibition.  If the 5’-exon mimic binds the 
intron that has already spliced out and cyclized, it will open the circle and become ligated 
to the 5’-end of the intron (Figure 3.1, H-I).  This is called the reverse cyclization 
reaction.  Both of these catalytic reactions rely on the molecular interaction of the IGS of 
the intron with an exon mimic, and allow us to analyze what sequences can bind and 
react.   
The results show that additional 5’ exon mimics, other than the complementary 
mimic to the IGS, can be substrates in the suicide inhibition and the reverse cyclization 
reactions.  Reactions run with ribozymes, changed in their IGS sequences, show that the 
IGS itself can be altered to target a diverse variety of substrate sequences. These 
alterations may give complementary base paired P1 helices, but the changes can affect 
the thermodynamics of P1 helix base pairing and tertiary interactions. The results from 
this combinatorial study have given us a greater understanding of the fundamental 
molecular recognition properties of P. carinii IGS-mediated reactions. 
 
A Tetrahymena Ribozyme Performs the Trans Excision-Splicing Reaction 
The trans-excision splicing reaction (TES) is a group I intron-derived reaction 
where the ribozyme base pairs with an exogenous RNA substrate, excises a specific 
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segment, and ligates the ends of the RNA substrate back together (Figure 4.1) (6).  This 
TES reaction was developed with a group I intron derived ribozyme from the 
opportunistic pathogen P. carinii and has been extensively studied (6, 20, 21).  To show 
that the TES reaction is more general to group I intron-derived ribozymes, we tested 
whether another group I intron-derived ribozyme could perform the TES reaction.  A 
group I intron from the ciliate Tetrahymena thermophila has predominantly been used to 
study self-splicing and develop new ribozyme reactions.  Therefore, we wanted to see if 
the Tetrahymena ribozyme could perform the TES reaction and if so, compare it to the P. 
carinii TES reaction.   
The Tetrahymena-derived ribozyme performs the TES reaction, indicating that the 
TES reaction is not specific to the P. carinii derived-ribozyme.  The Tetrahymena TES 
reaction has lower optimized product yields and decreased observed rate constants for 
both the first and second steps of the reaction compared to the P. carinii ribozyme, 
suggesting that the P. carinii ribozyme might be better at the TES reaction.  Two hybrid 
ribozymes, with the IGS of either ribozyme switched, were also tested.  By exchanging 
the IGS of each ribozyme, we can compare separately the ability of either the ribozyme 
or the native substrates to perform the TES reaction.  The results suggest that the TES 
reaction is a general group I intron-derived ribozyme reaction, although the P. carinii 
ribozyme is substantially better at the TES reaction than the Tetrahymena ribozyme.  
Both the specific base paired P1 and P10 helices and the catalytic core of the individual 
ribozyme appear to contribute to the accuracy and efficiency of the TES reaction.   
 
The P. carinii Ribozyme Performs a New Reaction, Trans Insertion-Splicing 
 A new group I intron-derived ribozyme reaction called trans insertion-splicing 
(TIS) was developed, where one RNA substrate is directly inserted into a second RNA 
substrate (Figure 5.7).  The P. carinii ribozyme that performs the TES reaction also 
performs the TIS reaction, although the TIS reaction is not the reverse of the TES 
reaction.  The unique TIS mechanism proceeds through three nucleophilic attacks and 
involves formation of two separate P1 helices, showing that group I introns are capable of 
more dynamic reactions than previously thought.   
 3 
The TIS reaction is the first example of the direct insertion of one exogenous 
RNA into a second exogenous RNA using a ribozyme essentially unaltered from its 
intronic form.  The molecular recognition interactions between the ribozyme and the two 
TIS substrates were analyzed and this new ribozyme reaction mechanism was elucidated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Ashley Kirtley Johnson 
 4 
CHAPTER TWO - Background on Catalytic RNA 
 
Central Dogma of Molecular Biology 
 In the central dogma of molecular biology, DNA is transcribed into RNA and 
RNA is translated into protein (Figure 2.1) (22)  Clearly, RNA has a central and very 
important role in protein synthesis (Figure 2.2).  There are three main classes of RNA 
found in the cell: 1) Messenger RNA (mRNA) codes for amino acids (the building blocks 
of protein), and its sequence is recognized in three nucleotide long segments called 
codons; 2) Transfer RNA (tRNA) has an amino acid attached and recognizes the codon 
sequence of the mRNA (Figure 2.2); and 3) Ribosomal RNA (rRNA) is part of the 
ribosome complex where proteins are synthesized.  The majority of RNA found in the 
cell is rRNA (80-85%).  tRNA makes up 10-15% of the RNA in the cell, and the least 
stable of the three, mRNA, represents less than 5% (23). 
 
Deoxyribonucleic Acid 
DNA, or deoxyribonucleic acid, is a polymer made up of nucleotides.  These 
nucleotides contain a deoxyribose sugar, a nucleobase, and a phosphate (Figure 2.3.A).  
DNA nucleotides form a polymer linked together through a phosphodiester backbone.  
This phosphodiester backbone has directionality from the 5’-carbon to the 3’-carbon on 
the sugar.  DNA is typically double stranded and base pairs with a complementary strand 
that is anti-parallel (in a 3’ to 5’ direction).  The base pairs are formed by hydrogen 
bonding between the nucleobases (Figure 2.3.B).  Watson-Crick base pairs are adenine 
and thymine (forming two hydrogen bonds) and guanine and cytosine (forming three 
hydrogen bonds).  The nucleotides are generally identified by their letter abbreviations 
(A, C, G, and T).  The geometry of the two sets of base pairs are isosteric, so A-T pairs 
can replace C-G pairs and visa versa without changing the geometry of the helix.  
Essentially, the Watson-Crick base pairs allow for the unique double helix structure of 
DNA (Figure 2.3.C).       
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Ribonucleic Acid 
 RNA, or ribonucleic acid, is also a polymer made up of nucleotides.  The main 
difference between RNA and DNA is that RNA contains a ribose sugar instead of a 
deoxyribose.  The ribose sugar has a hydroxyl group on its 2’-carbon (Figure 2.4.A, 
highlighted in gray), essentially giving RNA nucleotides an extra functional group 
compared to DNA.  This extra functional group makes RNA chemically less stable than 
DNA and allows for RNA to have catalytic function.  Another difference between RNA 
and DNA is that RNA uses the nucleobase uracil and DNA uses thymine.  Uracil differs 
from thymine by containing one less methyl group (compare Figures 2.3.B and 2.4.B).   
RNA, like DNA, is a polymer with a phosphodiester backbone linked in a 5’ to 3’ 
direction (Figure 2.4.B), but RNA is typically single stranded (does not have a 
complementary strand like DNA).  Therefore, it can base pair with complementary 
sections of itself, producing secondary structures such as hairpins and pseudoknots 
(Figure 2.4.C).  The secondary structure of tRNA forms several hairpins and is often 
referred to as a cloverleaf pattern (shown in Figure 2.2).  RNA secondary structures form 
A-U and C-G Watson-Crick base pairs (Figure 2.5).  In addition, energetically less stable 
non-Watson-Crick base pairs, such as the G-U wobble pair, are also formed (Figure 2.5).  
The G-U wobble pair has different functional groups available for interactions (Figure 
2.5, indicated with gray circles), compared to Watson-Crick base pairs.     
Secondary structure often leaves unpaired nucleotides in the form of loops (Figure 
2.4.C) and bulges that can interact with substrates or other regions of the RNA.  A loop in 
tRNA called the anti-codon recognizes the codon in the mRNA through base pairing 
(Figure 2.2).  These unpaired regions also add to the three-dimensional tertiary structure 
that gives large RNAs a globular shape, similar to proteins.   
 
RNA Splicing 
 In eukaryotes, after RNA is transcribed and before it is translated, it is altered in a 
process called post-transcriptional modification.  Transcribed RNA can be thought of as 
regions of exons (expressed sequences) and introns (intervening sequences) as depicted 
in Figure 2.6.  Through a process called RNA splicing, introns are removed, resulting in 
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the exons being ligated together to form mature RNA (24).  Phillip Sharp and Richard 
Roberts received the 1993 Nobel Prize in medicine for their discovery of RNA splicing.  
Through a process called alternative splicing, removal of various introns allows for 
different RNAs to be generated from the same gene.   
 
Catalytic RNA 
 Catalytic RNAs have specific three-dimensional shapes that form active sites.  
The active sites recognize substrates and position them for catalysis, thus lowering the 
activation energy for the reaction.   Catalytic RNA was discovered by Thomas Cech, as 
an intron from the ciliate Tetrahymena thermophila capable of self-splicing without the 
need for proteins (1) (Figure 2.7.A).  Concurrently, Sidney Altman demonstrated that the 
catalytic portion of Ribonuclease P (an RNA and protein complex) was RNA (2).  The 
idea that RNA could catalyze a reaction revolutionized the biological view of RNA and 
won Cech and Altman the 1989 Nobel Prize in Chemistry. 
 
Group I Intron Self-Splicing 
 Introns are classified based on their conserved secondary structure, as well as 
their splicing reaction mechanism.  The self-splicing mechanism and secondary structure 
for a group I intron from the fungal pathogen Pneumocystis carinii is depicted in Figure 
2.7.  Group I introns perform self-splicing through two nucleophilic attacks (Figure 
2.7.A) (25, 26).  The first attack occurs by a hydroxyl (OH) group on an exogenous 
guanosine (G) at the 5’exon-intron junction (see Figure 2.7.A, marked 1st).  This attack 
causes release of the intron from the 5’exon and leaves a free 3’-OH on the 5’exon.  In 
the second nucleophilic attack, this free 3’-OH on the 5’exon attacks at the intron-3’exon 
junction (see Figure 2.7.A, marked 2nd).  The second attack results in ligation of the two 
exons and release of the intron. 
   The secondary structure of group I introns is defined by ten conserved base paired 
regions labeled P1-P10 (Figure 2.7.B).  These base paired regions form helices and 
unpaired loops that are then involved in tertiary interactions.  The secondary and tertiary 
structure of the group I intron helps position the exons for attack at the 5’ and 3’-splice 
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sites.  The 5’-exon base pairs with the intron, forming the P1 helix (see Figure 2.7.B, 
5’exon in pink).  The first attack occurs at the 5’-exon/intron junction and is directed by 
formation of the P1 helix.  A highly conserved G-U wobble pair helps define the 5’-splice 
site (27, 28).  The G-U wobble pair has different functional groups available compared to 
Watson-Crick base pairs.  One functional group in particular, an exocyclic amine (Figure 
2.5), is directly involved in catalysis at the 5’splice site (29, 30).  The first nucleophilic 
attack occurs by the 3’-hydroxyl group on an exogenous guanosine (G), attacking the 5’-
splice junction (Figure 2.7.B).   
To position the 3’ exon for the second step of self-splicing, the 3’exon forms a 
P10 helix with the intron (see Figure 2.7.B, 3’exon in light blue).  The second 
nucleophilic attack is performed by a 3’-OH on the 5’-exon that was made available after 
the first nucleophilic attack.  The second nucleophilic attack occurs at the junction 
between the intron and the 3’-exon.  This attack occurs after the last nucleotide in the 
intron, a conserved omega G (ωG), and results in ligation of the two exons and release of 
the intron sequence. 
  The intron recognizes its substrates and positions them for catalysis through 
several important interactions.  The internal guide sequence (IGS) is the sequence in the 
intron that forms the P1 and P10 helices (31).  This sequence helps the intron recognize 
its substrate through base pairing.  The P1 and P10 helices also form tertiary interactions 
with the intron by docking into the catalytic core (17, 18, 32, 33).  The guanosine binding 
site (GBS) is a site in the intron that interacts with the exogenous G and positions it for 
the first nucleophilic attack of self-splicing (34).  The GBS is highlighted in yellow in 
Figure 2.7.B.  After the first nucleophilic attack, the ωG of the intron is positioned into 
the GBS to help direct the second nucleophilic attack (35-37).  The 3’-end of the intron 
forms a P9.0 helix (Figure 2.7.B) that helps position the ωG into the GBS.     
 
Group I Intron-Derived Ribozymes 
Group I introns are frequently exploited as model systems to pursue a more 
thorough understanding of RNA structure and function. Since the self-splicing reaction is 
single-turnover, studies often utilize group I intron-derived ribozymes.  These ribozymes 
are essentially introns that lack their endogenous 5’ and 3’ exons (16, 17).  Therefore, 
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group I intron derived-ribozymes recognize exogenous substrates and utilize the same 
molecular recognition interactions that the intron uses in the self-splicing reaction.  New 
ribozyme reactions are developed to exploit the molecular recognition interactions and 
the inherent catalytic properties of the intron.  In addition, it has been shown that the IGS 
sequence of these ribozymes can be altered to target the ribozyme to different substrates, 
such that complementary base pairing is maintained within the P1 helix (5, 31, 38, 39). 
This characteristic has been exploited for engineering group I intron-derived ribozymes 
that target and react with specific sequences.  
 
The Trans Excision-Splicing Reaction 
The trans excision-splicing (TES) reaction results in removal of specific 
nucleotides from the center of an RNA substrate.  Specifically, the TES ribozyme cuts 
open an RNA substrate, removes a section in the middle, and splices the ends of the 
substrate back together (6).  The TES reaction was demonstrated using a P. carinii 
ribozyme and is related to the group I intron self-splicing reaction.  The two nucleophilic 
attacks in the TES reaction and the secondary structure of the P. carinii-derived ribozyme 
are shown in Figure 2.8.  The P. carinii ribozyme recognizes the TES substrate in part 
through base pairing (Figure 2.8.B).  The 5’ and 3’ ends of the TES substrate are 
essentially 5’ and 3’ exon mimics (Figure 2.8, 5’exon mimic in pink and 3’exon mimic in 
light blue).  The TES reaction results in removal of an internal segment (Figure 2.8, 
shown in green) and ligation of the two exon mimics (TES product).   
Similar to self-splicing, the TES reaction proceeds through two nucleophilic 
attacks.  The 5’-exon mimic in the substrate base pairs with the ribozyme, forming a P1 
helix (Figure 2.8.B, 5’exon mimic in pink).  The first site of attack occurs at the 5’-exon 
mimic/intron junction (5’-splice site) and is directed by formation of the P1 helix.  The 
first nucleophilic attack occurs by a free hydroxyl group from the buffer at the 5’-splice 
site (unlike self-splicing that utilizes an exogenous G).  To position the 3’ exon mimic for 
the second nucleophilic attack, the 3’exon mimic forms a P10 helix with the ribozyme 
(Figure 2.8.B, 3’exon mimic in light blue).  The G being removed (Figure 2.8, in green) 
acts like the ωG from the intron, and probably interacts with the GBS in the ribozyme.  
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The second nucleophilic attack is performed by a 3’-hydroxyl on the 5’-exon mimic that 
was made available after the first nucleophilic attack.  The second attack occurs at the 
junction between the G (Figure 2.8.B in green) and the 3’-exon mimic (Figure 2.8.B in 
light blue), thus resulting in ligation of the two exons mimics (Figure 2.8.A, TES 
product) and release of the G.     
 The TES reaction with the P. carinii ribozyme has been extensively studied.  The 
removed section can be as little as one nucleotide (required to be a G as described) and as 
long as 28 nucleotides (6).  The sequence of the IGS can also be changed to target the 
ribozyme to different substrates (6).  The length of the P10 and P9.0 helices can be 
increased to enhance the second step of the TES reaction (20).  Additionally, the TES 
reaction can still occur without a G-U wobble pair at the 5’splice site, although a G-U 
wobble pair at this position gives the greatest yield and rates for formation of TES 
product (21). 
 
Suicide Inhibition and Reverse Cyclization Reactions 
Introns in large RNA transcripts can self-splice and then the excised intron can 
react with itself in a cyclization reaction (40-42).  Therefore, the self-splicing and 
cyclization reactions occur consecutively (Figure 2.9.A).  Addition of an inhibitor to 
these reactions can prevent the self-splicing reaction and also open the circular intron.  
These reactions are called suicide inhibition and reverse cyclization. 
 In the suicide inhibition reaction, exogenous 5’ exon mimics can compete with 
the 5’-exon, bind the IGS of the intron, and form a P1 helix.  5’exon mimics that bind and 
react prevent the self-splicing reaction and become ligated to the 3’exon (Figure 2.9.B) 
(43-45).  This reaction is called suicide inhibition because the inhibitor disrupts self-
splicing and is actually used in the reaction.   
The reverse cyclization reaction occurs concurrently with suicide inhibition.  
Some of the introns that self-splice react with themselves and form a cyclized product 
(Figure 2.9.A).  These circular introns still contain their IGS.  The same suicide inhibitor 
added to the reaction can base pair with the IGS of the cyclized intron, forming a P1 
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helix.   If the inhibitor binds and reacts, it opens up the cyclized intron and becomes 
ligated to the 5’-end of the intron (Figure 2.9.C) (31, 46, 47).   
In both of these reactions, the inhibitor becomes ligated to part of the RNA 
transcript, allowing for relatively easy product analysis. 
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Figure 2.1.  The central dogma of molecular biology.  DNA is the heredity material that 
codes for RNA in a process called transcription (22).  RNA codes for protein in a process 
called translation. 
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Figure 2.2.  Translation of RNA.  DNA is transcribed into RNA, and RNA is translated 
into protein.  In protein synthesis, RNA has several functions: as messenger RNA 
(mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA).  mRNA codes for the 
protein sequence in three nucleotide segments called codons.  The codon ACU codes for 
the amino acid threonine (blue).  And likewise, UAC codes for tyrosine (green), and 
GUC codes for valine (red).  tRNA brings amino acids to the ribosome.  The anti-codon 
in the tRNA binds the codon in the mRNA.  The protein synthesis occurs in the ribosome 
(yellow circle), which is an rRNA/protein complex.  The protein grows longer as tRNAs 
bring more amino acids until a stop codon in the mRNA is reached (48). 
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Figure 2.3. DNA nucleotides, double stranded DNA, and the double helix.  A) 
Deoxyribonucleic acid (DNA) is made up of nucleotides.  DNA nucleotides consist of a 
phosphate, a deoxyribose sugar, and a nucleobase.  B) DNA forms a phosphodiester 
backbone in a 5’ to 3’ direction.  A complementary strand running 3’ to 5’ forms base 
pairs with the nucleobases.  Four different nucleobases are found in DNA; adenine, 
thiamine, guanine, and cytosine.  Adenine forms two hydrogen bonds with thymine and 
guanine forms three hydrogen bonds with cytosine.  C) The double helix of DNA forms 
by twisting of two complementary paired DNA strands.  
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Figure 2.4. RNA nucleotides, single stranded RNA, and RNA secondary structures.  A) 
Ribonucleic acid (RNA) is made up of nucleotides.  RNA nucleotides consist of a 
phosphate, a ribose sugar, and a nucleobase.  RNA differs from DNA by having an 
additional functional group (the OH highlighted in gray).  B) RNA forms a 
phosphodiester backbone in a 5’ to 3’ direction.  Four different nucleobases are found in 
RNA; adenine, uracil, guanine, and cytosine.  RNA is typically found single stranded, 
although it can base pair with itself.  Adenine forms two hydrogen bonds with uracil and 
guanine forms three hydrogen bonds with cytosine.  C) RNA forms secondary structures 
when it base pairs with itself.  These structures typically have unpaired loops and bulges, 
as seen in the hairpin and pseudoknot.  
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Figure 2.5.  Watson-Crick versus wobble base pairs.  Watson-Crick base pairs have the 
same geometry, so either a G-C or an A-U pair gives the same dimensions.  A G-U 
wobble base pair forms two hydrogen bonds and is less energetically stable than a 
Watson-Crick base pair.  There are also different functional groups available when the G-
U wobble pair forms (highlighted in gray). 
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Figure 2.6. RNA undergoes post-transcriptional modifications.  Intervening sequences 
called introns are spliced out of the RNA transcript to form mature RNA.  
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Figure 2.7. Group I intron self-splicing and secondary structure of a P. carinii group I 
intron.  A) Group I intron self-splicing proceeds through two nucleophilic attacks.  The 
first attack occurs by a 3’-OH group on an exogenous G at the 5’-exon/intron junction.  
The second attack occurs by a free 3’-OH on the 5’-exon at the intron/3’-exon junction.  
B) The secondary structure of group I introns is defined by the conserved base paired 
regions labeled P1-P10.  The 5’-exon is in pink, the 3’-exon is in light blue, and the rest 
of the sequence makes up the intron.  The 5’ and 3’-exons base pair with the intron to 
help position them for catalysis.  The first and second positions of nucleophilic attack are 
labeled.  The first attack occurs at the end of the P1 helix at a highly conserved G-U 
wobble pair.  The second attack occurs at the end of the P10 helix at the ωG in the intron.  
The exogenous G and the ωG interact with the G binding site (GBS) marked by the 
yellow circle. 
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Figure 2.8. The trans excision-splicing reaction and secondary structure of a P. carinii 
group I intron-derived ribozyme.  The 5’-exon mimic is shown in pink.  The 3’-exon 
mimic is shown in light blue.  The region to be removed in the TES reaction is shown in 
green.  Arrows labeled 1st and 2nd denote the two nucleophilic attacks.  A) The TES 
reaction proceeds through two nucleophilic attacks.  The first attack occurs by a free OH 
group from the buffer at the 5’-exon mimic/intron junction.  The second attack occurs by 
a free 3’-OH on the 5’-exon mimic at the intron/3’-exon mimic junction.  B) The 
secondary structure of group I introns is defined by the conserved base paired regions 
labeled P1-P10.  The group I intron-derived ribozyme has its exon sequences removed.  
The 5’ and 3’-exon mimics base pair with the ribozyme to help position them for 
catalysis.  The first and second positions of nucleophilic attack are labeled.  The first 
attack occurs at the end of the P1 helix at a highly conserved G-U wobble pair.  The 
second attack occurs at the end of the P10 helix at the ωG in the region being removed. 
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Figure 2.9.  The suicide inhibition and reverse cyclization reactions.  A) The group I 
intron self-splicing and cyclization reactions occur consecutively.  B) Exogenous 5’ exon 
mimics can bind the IGS and react with the intron before self-splicing, thereby acting as 
suicide inhibitors of the self-splicing reaction.  If the inhibitor binds and reacts, it 
becomes ligated to the 3’-exon and prevents self-splicing.  C) The reverse cyclization 
reaction occurs concurrently with the suicide inhibition reaction.  Introns that self-splice 
can react with themselves and form a cyclized product that still contains the IGS.  If the 
inhibitor binds and reacts, it opens up the cyclized intron and becomes ligated to the 5’-
end of the intron. 
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CHAPTER THREE - Molecular Recognition Properties of IGS-
Mediated Reactions Catalyzed by a Pneumocystis carinii Group I Intron 
 
Introduction 
 
Self-splicing group I introns are catalytic RNAs that splice out of cellular RNA 
transcripts (Figure 3.1, A-C), often without the apparent requirement for ancillary 
proteins (1). The excised introns can then react with themselves in a process called 
cyclization (Figure 3.1, D-E) (40-42). Group I introns recognize their exons through base 
pairing at their internal guide sequence (IGS).  Both the intron with its exons attached 
(before self-splicing) and the cyclized intron contain an IGS and can react with substrates 
that bind to it.  In the suicide inhibition reaction, an exogenous 5’ exon mimic can 
compete with the native exon, bind the intron, and react, becoming ligated to the 3’exon 
in the process (Figure 3.1, F-G) (43-45).  This reaction disrupts the self-splicing reaction 
and is therefore called the suicide inhibition reaction.  Also, the same exogenous 5’ exon 
mimic can bind the IGS of the cyclized intron and react, opening up the cyclized intron 
and becoming ligated to its 5’-end (Figure 3.1, H-I) (31, 46, 47).  This reaction opens up 
the circle and is called the reverse cyclization reaction.  Both of these catalytic reactions 
rely upon the molecular interaction of the IGS with its exon mimic.  
Although the sequence dependence of the 5' exon-IGS interaction has been 
studied using Tetrahymena ribozymes (in trans-splicing and reverse splicing reactions), 
the sequence dependence of this interaction has not been analyzed for any P. carinii 
ribozyme reaction, or for the suicide inhibition reaction with any ribozyme. This is of 
interest because previous results have shown that the P. carinii and Tetrahymena 
ribozymes utilize a different array of tertiary interactions to dock the P1 helix into the 
catalytic core (17-19). Essentially, the Tetrahymena ribozyme has been shown to 
recognize the particular structure of the P1 helix, whereas the P. carinii ribozyme appears 
to recognize specific base pairs in the P1 helix.  Furthermore, the P. carinii ribozyme 
catalyzes a unique trans excision-splicing reaction, which along with the suicide 
inhibition reaction has potential applications.  These potential applications involve 
manipulating RNA sequences in vitro and in vivo.  It was of interest then to analyze the 
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sequence dependence (and increase our understanding of this key molecular recognition 
interaction) for the P. carinii suicide inhibition reaction.  Since the cyclization and 
reverse cyclization reactions occur concurrently with self-splicing and suicide inhibition, 
the results from the reverse cyclization reaction were also analyzed. 
A combinatorial approach, using randomized 5’ exon mimics, allowed us to 
assess the sequence specificity of the P. carinii IGS.  The results show that certain 5’ 
exon mimic chimeras, other than that complementary to the IGS, can be substrates in the 
suicide inhibition and the reverse cyclization reactions. The distribution of substrate 
sequences is not random, as only certain mismatches are permissible at each of the five 
randomized 5’ exon positions. Exon sequences that maintain Watson-Crick or wobble 
base pairs with the IGS, especially within the four 3’ nucleobases of the 5’ exon, are the 
most effective substrates in these reactions. The sequence specificity of the suicide 
inhibition reaction is MgCl2 dependent, with a more diverse array of acceptable substrate 
sequences at higher MgCl2 concentrations. Our results also indicate that the reverse 
cyclization reaction is substantially more sequence specific than the suicide inhibition 
reaction. Furthermore, we report that the reverse cyclization products stem from multiple 
cyclized intron intermediates, which consequently lead to multiple reverse cyclization 
products.  
Using the P. carinii intron and a ribozyme derived from this intron (42, 49), the 
binding properties of a representative group of synthetic 5’ exon mimic chimeras were 
quantified. In these studies, we demonstrate the importance of a base pair (position –4 of 
the P1 helix) for tertiary docking of the P1 helix into the catalytic core of the intron. 
Finally, data shows that the IGS itself can be altered to target a diverse variety of 
substrate sequences. Such alterations, however, even though resulting in fully 
complementary P1 helices, can significantly affect the thermodynamics of P1 helix base 
pairing and tertiary docking. This combinatorial approach therefore has proven useful for 
gaining a deeper understanding of the fundamental molecular recognition properties of 
IGS-mediated reactions. 
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Materials and Methods 
 
Synthesis and Purification of Nucleic Acids 
The oligonucleotide d(GCTCGTCGTCGACAACGGCTCATGAC)rU [named 
Pr2-d(ATGAC)rU] was synthesized on an Applied Biosystems 380B DNA/RNA 
synthesizer and purified by trityl-on reverse phase column chromatography (Sep-Pak, 
Milford, MA) as described (17). The oligonucleotides d(GCTCACTCATTAGGCACC) 
[named Pr1], d(GCTCGTCGTCGACAACGGCTC) [named Pr2], 
d(GCTCGTCGTCGACAACGGCTCNNNNN)rU [named Pr2-d(NNNNN)rU], 
d(CAACATTGTTACTATACCCAGGGCT) [named Pr3], 
d(GACAGTGTCGCAATCTGAAT) [named Pr4] and all the chimeric hexamers were 
synthesized, deblocked, and desalted by Integrated DNA Technologies (Coralville, IA). 
N represents machine randomization of all four bases at the designated positions. The all 
RNA oligonucleotides were synthesized by Dharmacon Research, Inc. (Lafayette, CO). 
All hexamers (RNAs and chimeras) were purified by thin-layer chromatography as 
described (17). Designated oligonucleotides were 5’ end radiolabeled and purified by 
polyacrylamide gel electrophoresis (PAGE) as previously described (17). 
Oligonucleotide concentrations were calculated based on UV-absorption measurements 
using a Beckman DU 650 UV-Spectrophotometer (Beckman Coulter, Inc., Fullerton, 
CA).  
The ribozyme rPC, which was used in the binding assays, was synthesized by run-
off transcription of XbaI linearized P-8/4x plasmid (17). The group I intron transcript rP-
h, which was used for the reverse cyclization, cyclization, initial suicide inhibition, and 
the kinetic assays was synthesized by run-off transcription of HindIII linearized P-h 
plasmid (17). This produces an RNA transcript with an 82 base 5’ exon, 344 base intron, 
and 27 base 3’ exon. The group I intron transcript rP-V, used in the combinatorial suicide 
inhibition assay, was synthesized by run-off transcription of VspI linearized P-h plasmid. 
This produces an RNA transcript with an 82 base 5’ exon, 344 base intron, and 233 base 
3’ exon. The rP-V transcript is an elongated version of rP-h with the 3’ exon extended 
such that it can serve as a primer-binding region for RT-PCR in the combinatorial suicide 
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inhibition assay. Note that the 206 base extended region is derived entirely from the P-h 
plasmid and is not native to the P. carinii intron or flanking exons. 
 For designated studies the IGS of the rPC ribozyme was modified from 
r(GGUCAU) to either r(GGUGAU) or r(GUGACG). These mutant ribozymes were 
named rPC-CtoG and rPC-oppo, respectively. Site-directed mutagenesis was performed 
on the plasmid precursor, P-8/4x, using the following mutagenic primer pairs: for rPC-
CtoG, CGACTCACTATAGAGGGTGATGAAAGCGGC and 
GCCGCTTTCATCACCCTCTATAGTGAGTCG; and for rPC-oppo, 
CGACTCACTATAGAGGTGACGGAAAGCGGC and 
GCCGCTTTCCGTCACCTCTATAGTGAGTCG. Each modified plasmid was generated 
in a 50 μL reaction consisting of 25 ng P-8/4x plasmid, 2.5 units Pfu DNA polymerase 
(Stratagene; La Jolla, CA), and 0.5 μM dNTPs in a buffer of 10 mM KCl, 10 mM 
(NH4)2SO4, 20 mM Tris-HCl (pH 8.8), 2 mM MgSO4, 0.1% Triton X-100, and 0.1 
mg/mL BSA. The mixtures were initially denatured at 95 OC for 30 seconds, then 
underwent 15 cycles of 95 OC (30 sec), 50 OC (2 min), and 68 OC (6 min) in a 
PCRExpress Thermal Cycler (Hybaid; Ashford, Middlesex, UK). The parental plasmids 
were digested with 20 units of DpnI (Gibco BRL, Rockville, MD) in 5.7 μL of the 
manufacturer’s buffer at 37 OC for 2 hours. A 3 μL aliquot was used to transform E. coli 
DH5α competent cells (Gibco BRL). Individual isolates were grown and the modified 
plasmids were purified using a QIAprep Spin Miniprep Kit (QIAGEN; Valencia, CA). 
The plasmids were sequenced for confirmation (ACGT, Inc; Northbrook, IL).  The two 
mutant ribozymes were transcribed as described for rPC (17). 
 
MgCl2 Concentration Dependence of Group I Intron Reactions 
Initially, as a test of reactivity, the suicide inhibition and reverse cyclization 
reactions were conducted as a function of MgCl2 concentration using the radiolabeled 5’ 
exon mimic chimeras d(ATGAC)rU and Pr2-d(ATGAC)rU. In the experiments with 
d(ATGAC)rU, 3 μL of 667 nM rP-h was preannealed at 55 OC in HXMg buffer [50 mM 
Hepes (25 mM Na+), 135 mM KCl, and X mM MgCl2 (from 0 to 15) at pH 7.5] for 5 min 
and slow cooled to 37 OC.  A 1 μL solution of 1 nM 5’ end radiolabeled d(ATGAC)rU at 
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37 OC was added. The final concentration of rP-h in the d(ATGAC)rU assays was 500 
nM because the expected dissociation constant for d(ATGAC)rU was 60 to 100 nM (in 
15 mM MgCl2 at 37 OC). The reaction was allowed to proceed at 37 OC for 2 hours. The 
experiments utilizing Pr2-d(ATGAC)rU were conducted as above, except for using a 
final concentration of 5 μM rP-h in H4Mg or H15Mg buffer. The concentration of rP-h 
for the Pr2-d(ATGAC)rU reactions was 10-fold higher than that with d(ATGAC)rU, 
which was required due to less efficient reactivity with the former. The reactions were 
quenched by the addition of 4 μL stop buffer (0.1X TBE, 10 M urea, and 3 mM EDTA) 
and the reactants and products were separated on an 8% polyacrylamide, 7.5 M urea gel.  
The gel was dried under vacuum and the bands were visualized and quantified on a 
Molecular Dynamics Storm 860 Phosphorimager. Note that this reaction produces visible 
suicide inhibition and reverse cyclization products, whose ratio depends on the solution 
concentration of MgCl2. Also note that these reactions were done in the absence of free 
guanosine monophosphate to enhance suicide inhibition relative to self splicing (43). The 
high rate of ribozyme-mediated hydrolysis at the 5’ exon-intron junction, however, still 
allows a significant amount of self-splicing, and hence formation of the circularization 
intermediate, to occur (17, 43). 
 
Combinatorial Assays 
For the suicide inhibition reactions, 1 μM of rP-V precursor was preannealed at 
55 OC in 5 μL of either H4Mg or H15Mg buffer for 5 min and slow cooled to 37 OC.  A 5 
μL solution of either 400 nM Pr2-d(ATGAC)rU or Pr2-d(NNNNN)rU in the appropriate 
buffer at 37 OC was added and the reaction was allowed to proceed for 1 h.  The reverse 
cyclization and cyclization reactions were conducted essentially the same as the suicide 
inhibition reactions, except that the rP-h intron transcript was used and the assay was 
performed only in H15Mg buffer. In these combinatorial assays, the final concentration 
of rP-V or rP-h was 500 nM and the final concentration of Pr2-d(ATGAC)rU or Pr2-
d(NNNNN)rU was 200 nM. A concentration of 200 nM of the randomized 
oligonucleotides gives approximately 0.2 nM of each particular sequence. 
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Product Isolation and Identification 
The reaction products were first reverse transcribed using primer Pr1 for suicide 
inhibition, primer Pr3 for reverse cyclization, and primer Pr4 for the cyclization reaction. 
The binding sites for these primers are shown in Figure 3.1. In these reactions, 2 μL of 
the final non-radiolabeled reaction mixture was added to 3.2 μL sterilized H2O, 0.5 μL of 
a 10 mM stock of all four dNTPs, as well as 0.3 μL of a 3.3 μM stock of the respective 
RT primer. This was incubated at 65 OC for 5 min and then quick cooled on ice. At this 
point, 2 μL of 5x reverse-transcription buffer [250 mM Tris-HCl (pH 8.3), 375 mM KCl, 
and 15 mM MgCl2], 1 μL of 0.1 M DTT, and 0.5 μL (20 units) RNAseOut (GibcoBRL) 
was added. This was incubated at 42 OC for 1 minute, after which 0.5 μL (100 units) of 
Superscript II (GibcoBRL) was added and the reaction incubated at 42 OC for 50 minutes. 
The reaction was terminated by incubation at 70 OC for 15 minutes and then was quick 
cooled on ice. The reverse transcription products were then PCR amplified. Briefly, 
reactions contained PCR buffer [50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.1% Triton X-
100], 0.1 μL of the reverse transcription reaction from above, 200 nM primer Pr2, 200 
nM of the respective reverse transcription primer, 1.2 mM MgCl2, 20 μM dNTP mix, and 
1 μL of Taq Polymerase (5 units, GibcoBRL). An initial incubation of 2 minutes at 94 OC 
was followed by 30 cycles of 94 OC (45 sec), 55 OC (1 min), and 72 OC (1.5 min). The 
resulting PCR products were separated on a 2% agarose gel. The distinct bands at 150 
base pairs (suicide inhibition reaction), 175 base pairs (cyclization reaction), and 200 
base pairs (reverse cyclization reaction) were extracted and purified using QIAquick Gel 
Extraction Kits (Qiagen).  
We exploited the natural 3’ A overhangs of the purified PCR products to ligate 
them into pGEM-T vectors (Promega; Madison, WI). The 4 OC overnight ligation 
protocol recommended by the manufacturer was followed. The resultant plasmids were 
transformed into E. coli DH5α cells and plated. Colonies were picked from the plates and 
grown overnight in LB-ampicillin media. The resultant amplified plasmids were purified 
using QIAprep Spin Miniprep Kits (Qiagen).  
All plasmids were sequenced off the T7 promoter indigenous to the plasmid. 
Roughly half of the resultant plasmids were sequenced by Davis Sequencing (Davis, 
California). Otherwise, sequencing reactions (total volume of 6 μL) consisted of 250 ng 
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plasmid template, 1X sequencing buffer [50 mM Tris-HCl (pH 9.0) and 2 mM MgCl2], 
0.10 fmol 5’end radiolabeled T7 sequencing primer, 0.25 μL Taq Polymerase (1.25 units, 
GibcoBRL), and one of the following nucleotide mixtures: 300 μM ddATP and 13.3 μM 
of each of the four dNTPs; 400 μM ddCTP and 13.3 μM of each of the four dNTPs; 33.3 
μM ddGTP and 13.3 μM of each of the four dNTPs; or 200 μM ddTTP and 6.6 μM of 
each of the four dNTPs. The sequencing reactions were run in a PCRExpress thermal 
cycler. An initial incubation of 2 min at 95 OC was followed by 30 cycles of 95 OC (30 
sec), 46 OC (30 sec), and 70 OC (1 min). The reaction was quenched by adding 3 μL of 
sequencing stop buffer (10 mM EDTA in de-ionized formamide). The samples were 
heated for 2 min at 70 OC and immediately loaded onto a 6% denaturing polyacrylamide 
gel. The gels were transferred onto chromatography paper (Whatman 3MM CHR), dried 
under vacuum at 65 OC, and visualized on a Molecular Dynamics Storm 860 
Phosphorimager.  
 
Determination of Binding Constants 
The dissociation constant, Kd, of representative 5’ exon mimics binding to the rP-
h intron was approximated using the rPC ribozyme and the radiolabeled native 5’ exon 
mimic, r(AUGACU), in competition band-shift gel electrophoresis assays (17, 18). rPC 
(45 nM) was preannealed at 55 OC for 5 minutes in 5 μL of a solution of H15Mg buffer 
containing 4.5% glycerol (v/v). The solution was then slow cooled to 37 OC, at which 
time approximately 1 nM radiolabeled r(AUGACU) and various concentrations of 
representative 5’ exon mimic competitors in a total volume of 2.5 μL (in H15Mg buffer 
at 37 OC) was added. The final concentration of ribozyme was 30 nM and the competitor 
concentrations varied from 5 to 1500 nM. A ribozyme concentration of 30 nM was used 
because this will bind essentially all of the r(AUGACU), which has a Kd of 5.2 nM for 
this ribozyme under these conditions (17). The solutions equilibrated for 90 min. The 
fraction of 5’ exon mimic bound was partitioned from unbound on a 37 OC, 10% native 
polyacrylamide gel made with H15Mg buffer. The gel was dried under vacuum and the 
bands quantified with a Molecular Dynamics Storm 860 Phosphorimager. Dissociation 
constants were calculated by fitting the data to a mass-action equation describing 
competitive binding of two ligands to a peptide, as previously described (17, 50).  The 
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data reported is the average of at least two independent assays. Quantification of binding 
in H4Mg buffer using this assay was not accurate because binding was below detection 
limits (Kd > 1.5 μM). 
 
Optical Melting Curves 
The strength of base pairing between the representative 5’ exon mimics and an 
oligonucleotide mimic of the intron’s native IGS, r(GGUCAU), was analyzed through 
thermal denaturation experiments on a Beckman DU 650 UV-Spectrophotometer.  Melts 
were conducted using an incident UV wavelength of 280 nM at 100 μM total strand 
concentration in H15Mg buffer. Thermodynamic parameters were quantified as 
previously described (17). The data reported is the average of at least two independent 
assays. 
 
Kinetics 
The observed rate constants for the suicide inhibition and reverse cyclization 
reactions using the representative 5’ exon mimics were obtained under single-turnover 
‘intron excess’ conditions. In these experiments, 15 μL of an 833 nM solution of rP-h 
was preannealed at 55 OC in either H4Mg or H15Mg buffer for 5 min and slow cooled to 
37 OC. A 10 μL solution of approximately 1 nM 5’ end radiolabeled 5’ exon mimic in the 
same buffer at 37 OC was added, bringing the final rP-h concentration in the sample to 
500 nM. An rP-h concentration of 500 nM was used to permit hexamers with relatively 
high Kds to bind the intron. A 2 μL aliquot was periodically removed and added to 2 μL 
stop buffer over typically 120 min. The reactants and products were separated on an 8% 
polyacrylamide, 7.5 M urea gel.  The gel was dried under vacuum and the bands were 
visualized and quantified on a Molecular Dynamics Storm 860 Phosphorimager. The 
observed rate constants for the suicide inhibition and reverse cyclization reactions were 
calculated by fitting the data to a pseudo first-order rate equation as previously described 
(17).  The data reported is the average of at least two independent assays.  
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Modified IGS Studies 
The dissociation constants for IGS-modified ribozymes (rPC-CtoG and rPC-oppo) 
binding various 5’ exon mimics were determined by direct band-shift electrophoresis 
assays. These assays were conducted using various radiolabeled 5’ exon mimics; rPC, 
rPC-CtoG, or rPC-oppo ribozymes at various concentrations (from 50 to 1500 nM); and 
H15Mg as the binding and electrophoresis buffers. The ribozyme mixtures were 
preannealed at 55 OC for 5 minutes in 5 μL solutions of H15Mg buffer and 4.5% glycerol 
(v/v). The solutions were then slow cooled to 37 OC, at which time 2.5 μL of 
approximately 1 nM radiolabeled 5’ exon mimic (in H15Mg buffer at 37 OC) was added. 
The assay was completed as described for the competitive binding assays and quantified 
as described (17). Thermal denaturing experiments were conducted as described above, 
except modified 5’ IGS sequences [r(GGUGAU) and r(GUGACG)] with their 
complementary 5’ exon mimics [d(ATCAC)rU and d(CGTCA)rU] were analyzed.  
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Results 
 
Combinatorial Assay Rationale 
It was previously demonstrated that the N3’→P5’ phosphoramidate 5’ exon 
mimic d(AnTnGnAnCn)rU, where n represents a phosphoramidate linkage (19, 43, 51-
53), is a suicide inhibitor of the self-splicing reaction in vitro of a group I intron from the 
opportunistic pathogen P. carinii (Figure 3.1, F-G). In the suicide inhibition reaction, the 
exogenous 5’ exon mimic becomes ligated to the endogenous 3’ exon. This property 
makes the suicide inhibition reaction ideal for developing a combinatorial assay to 
systematically analyze the sequence dependence of the 5’ exon-IGS molecular 
interaction. In this combinatorial assay, a 5’ elongated version of the 5’ exon mimic (as 
seen in Figure 3.1) acts as a suicide inhibition substrate and the elongated base region is 
exploited as a primer-binding site for RT-PCR amplification of the suicide inhibitor 
sequence. The 3’ bases of the suicide inhibitor, which act as the 5’ exon mimic, are 
randomized, permitting the simultaneous assessment of all possible sequences to be 
substrates in the suicide inhibition reaction. In addition to the suicide inhibition product, a 
reverse cyclization product (previously described as the 350 product in reference (43)) is 
concurrently generated in this reaction (43, 46, 47, 54). Reverse cyclization substrates are 
also 5’ exon mimics in that they first base pair, at least in part, with the IGS of the intron 
(Figure 3.1, H). Therefore, this combinatorial assay can also analyze the sequence 
dependence of the reverse cyclization reaction.  
 
Suicide Inhibition and Reverse Cyclization Assay Development 
The 5’ exon mimic, d(ATGAC)rU [Kd = 61 nM at 37 OC in 15 mM MgCl2], binds 
to the P. carinii rPC ribozyme nearly as tightly as the N3’→P5’ phosphoramidate 
equivalent, d(AnTnGnAnCn)rU [Kd = 16 nM at 37 OC in 15 mM MgCl2] (51). The non-
modified DNA-RNA chimeras were tested to assess whether they could serve as active 
substrates in the suicide inhibition and the reverse cyclization reactions. The reactions 
were run as a function of MgCl2 concentration using the 5’ exon mimic d(ATGAC)rU, as 
well as the elongated 5’ exon mimic, Pr2-d(ATGAC)rU (Figure 3.2). Using 
d(ATGAC)rU, products of approximately 31 nucleotides in length (the suicide inhibition 
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product) and approximately 350 nucleotides in length (the reverse cyclization product) 
were produced, as expected (49). In addition, the MgCl2 dependence of these reactions is 
similar to that obtained with the phosphoramidate-modified 5’ exon mimics (43). When 
the elongated 5’ exon mimic, Pr2-d(ATGAC)rU, was used in the reaction, the product at 
approximately 31 nucleotides was replaced by a product at approximately 52 nucleotides 
(Figure 3.2, lanes A and B), as expected. For confirmation, the products of the reactions 
with the elongated 5’ exon mimic Pr2-d(ATGAC)rU (conducted at 4 mM MgCl2 for 
suicide inhibition and 15 mM MgCl2 for reverse cyclization) were RT-PCR amplified, 
cloned, and sequenced. The sequences obtained were those expected for the two reactions 
and are diagrammed in Figure 3.1 (with the randomized regions equal to d(ATGAC)). 
These results demonstrate that the elongated, non-modified chimeric 5’ exon mimic is a 
substrate in these reactions.  
 
Sequence Specificity of Suicide Inhibition 
The combinatorial suicide inhibition reaction was initially conducted in H4Mg 
buffer using the P. carinii rP-V intron and the non-radiolabeled, randomized 5’ exon 
mimic Pr2-d(NNNNN)rU. Suicide inhibition reactions were run in 4 mM MgCl2 because 
it is at (43) or near (Figure 3.2) the optimum concentration for suicide inhibition 
reactivity. The 3’ uridine was not randomized, as it is nearly universally conserved. The 
resulting mixture of products was RT-PCR amplified, cloned, and the suicide inhibition 
junctions were sequenced. The results in Table 3.1 show that the native 5’ exon sequence, 
d(ATGAC)rU, occurs most often (22%), however 56% of the sequences (18 out of 32) 
obtained are unique. These 5’ exon mimics can effectively compete with the endogenous 
RNA exon and the exogenous chimeric native exon for the IGS of the intron. Although 
the sequence-specificity is relatively low for this interaction, the distribution of tolerated 
bases at individual positions within the exon is not random (Table 3.1, C). The exon 
positions are numbered according to the intron transcript (17) and are shown in Table 3.1. 
Position –2 can tolerate a dT, which presumably forms a dT-rG wobble base pair, 
however, a Watson-Crick base pair is strongly favored. At position –3, dA and dG were 
found in equal proportions, so a Watson-Crick pair (dA-rU) or a wobble pair (dG-rU) is 
either strongly favored or required. Position –4 allows a dC and, albeit rarely a dT, thus 
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strongly favoring a Watson-Crick base pair. Positions –5 and –6 are significantly less 
specific for Watson-Crick or wobble pairs than the other positions, although they are not 
random and they do prefer Watson-Crick pairing.  
 
The MgCl2 Dependence of Suicide Inhibition 
The combinatorial assay was performed in 15 mM MgCl2 to determine if the 
concentration of magnesium has an effect on the sequence specificity of the suicide 
inhibition reaction. The results at 15 mM MgCl2 are similar to results at 4 mM MgCl2 
except there is significantly more sequence diversity (83% unique sequences as compared 
to 56%) at the higher magnesium concentration. A greater number of mismatches are 
tolerated at positions –2 through –4, which appear to be the most critical positions for 
docking of the resultant P1 helices ((19), this work). In addition, the native sequence is 
found almost half as often at the higher MgCl2 concentration. Taken together these results 
indicate that the sequence-specificity of the suicide inhibition reaction decreases at higher 
MgCl2 concentration. 
 
Sequence Specificity of Reverse Cyclization 
The proportion of substrates that form reverse cyclization products relative to 
those that form suicide inhibition products increases at higher MgCl2 concentrations 
((43), see also Figure 3.2), perhaps because high salt favors intron cyclization (31, 55). 
Therefore, the sequence specificity of reverse cyclization was analyzed at 15 mM MgCl2. 
The results show that the native sequence occurs 58% of the time (with 42% unique 
sequences). Apparently, the reverse cyclization reaction at 15 mM MgCl2 shows a 
substantially higher preference for the native 5’ exon mimic sequence than the suicide 
inhibition reaction at either 4 mM (22%) or 15 mM (13%) MgCl2. The results also show 
that the 5’ exon mimics ligate to at least 4 different positions at the 5’ end of the intron 
(compare results of Table 3.2 with Figure 3.1). Evidently, multiple routes of reverse 
cyclization occur. It is possible that this stems from the prior formation of multiple 
cyclized intron intermediates.  
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Identification of Cyclization Intermediates 
Amplification of the reverse cyclization reaction mixture with RT-PCR primers 
Pr2 and Pr4 resulted in a product whose sequence shows the identity of the intron’s 
cyclization junction. Table 3.3 shows the sequences of the cyclization junctions for 11 
product sequences. There are two Gs at the 3’ end of the intron (Figure 3.1, D, shown in 
white lettering) that can each act as nucleophiles in the cyclization process. In addition, 
there are at least 3 different 5’ intron positions (Figure 3.1, D, shown in black lettering in 
dark gray background) that are the acceptor sites for the two possible G nucleophiles. 
Apparently, there are multiple routes to cyclization, which ultimately lead to a mixture of 
reverse cyclization products. Similar results arise from a Tetrahymena group I intron (42, 
46, 55). 
 
Binding of Representative 5’ Exon Mimics to the rPC Ribozyme 
Representative 5’ exon mimics (most sequences were found in the combinatorial 
assays) were chemically synthesized and their binding strengths to the intron were 
approximated using competitive band-shift electrophoresis assays in H15Mg buffer with 
the rPC ribozyme. Quantification of binding in H4Mg buffer using this assay was not 
possible because binding was below detection limits (Kd > 1.5 μM). The competitive 
binding assays (Figure 3.3, Table 3.4) reveal that the hexameric 5’ exon mimics either 
bind the ribozyme with a Kd less than 200 nM or they are above the detection limits. 
Furthermore, addition of the primer binding region to an exon results in a 2-fold 
reduction in overall binding. The results also show that a wobble base pair at positions –
2, –3, or –6 (exon mimics #6, #5, and #3 in Table 3.4) changes the Kd at most by 
approximately two-fold compared to the complementary sequence (exon mimic #1). 
Therefore, it appears that wobble base pairs, where possible, are well tolerated in terms of 
overall binding strength.  
A mispair at position –4 of the exon (exon mimic #8) forms a dC-rC pair with the 
IGS and prohibits binding. From the combinatorial assay, in every exon where a mutation 
occurs at position –4, there is a T to G mutation at position –5. As seen in Table 3.4, this 
double mutant (exon mimic #7) binds the ribozyme reasonably tightly (Kd = 137 nM), 
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which is not due to the single G mutation (exon mimic #4) at position –5 (Kd = 158 nM). 
Apparently, poor binding due to mismatch formation at position –4 can be rescued by the 
addition of a specific mutation at position –5.  
 
Base Pairing of Representative 5’ Exon Mimics with the IGS, r(GGUCAU) 
The stability of the representative 5’ exon mimics base pairing with the IGS of the 
P. carinii ribozyme was approximated (51) by thermal denaturation analysis with the IGS 
mimic, r(GGUCAU), in H15Mg buffer. The results of at least two experimental trials 
(Table 3.4) indicate that the thermodynamic stabilities (–ΔGo37, BP) of the resultant hybrid 
helices are very similar, although significantly less than the all RNA helix. The most 
thermodynamically stable hybrid helix is formed with d(ATGAC)rU, which is the 
complementary 5’ exon sequence to the IGS. Helices containing one or more mismatches 
are only at most 0.3 kcal/mol less stable than the native exon hybrid helix, which 
translates into a two-fold decrease in base pairing strength. Therefore, none of the 
mismatched helices studied completely disrupts the ability of the exon mimics to base 
pair with the IGS. This indicates that exon mimics that do not bind to the ribozyme do so 
because of an inability to form critical tertiary interactions with the ribozyme. 
 
Kinetics of Representative 5’ Exon Mimics Reacting with the rP-h Intron 
The combinatorial assay exploits the ability of each of the 5’ exon mimics to not 
just bind, but also to react with the intron. Therefore, the observed rate constant, kobs, of 
each representative oligonucleotide forming suicide inhibition and reverse cyclization 
products at 4 mM and 15 mM MgCl2 was measured under single turnover ‘intron-excess’ 
conditions. Figure 3.4 shows a typical gel and graph using the 5’ exon mimic 
d(ATGAC)rU. Note that each individual assay produces both suicide inhibition and 
reverse cyclization products. Thus, the extent of reaction for these two products are not 
altogether independent of each other. The results are shown in Table 3.5. The observed 
rate constants are less for the chimeras than the all RNA mimic, indicating that the 
chimeras are less effective substrates in these reactions. For comparison, the kobs for the 
suicide inhibition and reverse cyclization reactions using r(AUGACU) are 5 to 6-fold less 
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than that for the self-splicing reaction under the same conditions (17). For the suicide 
inhibition reaction using the chimeras, the magnitude of kobs changes less than 3-fold as a 
function of either sequence or MgCl2 concentration, at least for those assays that were 
quantifiable. For the reverse cyclization reaction using the chimeras, the magnitude of 
kobs changes less than 3-fold as a function of sequence, but changes up to 7-fold as a 
function of MgCl2 concentration. Therefore for the chimeras, increasing the MgCl2 
concentration differentially enhances the reverse cyclization reaction relative to the 
suicide inhibition reaction. Note that the presence of the elongated P2 region disrupts 
reactivity under the conditions used. This is not problematic in the combinatorial assays, 
however, as a higher exon mimic concentration was used and the final products were 
ultimately RT-PCR amplified. 
 
Analysis of the Sequence Requirements at the –4 Position of the 5’ Exon 
Our results suggest that there is a critical requirement for a base pair at position –
4. To directly test whether a G(exon)-C(IGS) pair at exon position –4 is required [in 
contrast to a C(exon)-G(IGS) pair], a ribozyme (rPC-CtoG) was synthesized with a G in 
position –4 of the IGS (instead of a C) and its binding to the exon mimics d(ATGAC)rU 
and d(ATCAC)rU was analyzed (Table 3.6). Apparently, a C(exon)-G(IGS) base pair at 
position –4 does permit substrate binding, although binding strength decreases two-fold 
relative to the native G(exon)-C(IGS) base pair (274 nM versus 151 nM). This decrease 
is entirely at the level of base pairing, and thus does not result from a loss of tertiary 
interactions. Therefore, although the IGS can be changed to alter the sequence-specificity 
of the ribozyme, certain types of base pairs at certain positions are thermodynamically 
favored over other base pairs. In addition, the 5’ exon mimic d(ATCAG)rU does not bind 
to the ribozyme with the native IGS sequence (which forms a dC-rC mismatch at position 
–4) and the native 5’ exon mimic d(ATGAC)rU does not bind the rPC-CtoG ribozyme 
(which forms a dG-rG mismatch at position –4). Apparently in these two later cases the 
P1 helix loses the ability to dock into the catalytic core of the ribozyme, most likely 
through disruption of base pair specific tertiary interactions.  
As a preliminary test to see how much the IGS can be altered and still retain 
complementary exon mimic binding, the rPC-oppo ribozyme was synthesized. In this 
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ribozyme, every purine of a C-G pair in the IGS is replaced by a pyrimidine of a U-A 
pair, and vice-versa (except for the conserved terminal U-G pair). Results in Table 3.6 
show that the exon mimic d(CGTCA)rU does bind to this ribozyme, although the strength 
of binding is reduced approximately eight-fold (1130 nM versus 151 nM) compared with 
the native sequences. Interestingly, this decrease is entirely due to a loss of tertiary 
interactions, as the base pairing stability of the resultant 5’ exon-IGS helix increases 
(Table 3.4). This exon mimic does not bind the native 5’ IGS of rPC, nor did the native 5’ 
exon mimic bind the modified rPC-oppo ribozyme. Therefore, although changing the 5’ 
IGS can result in a change in the sequence that the ribozyme targets, this change can 
result in a drastic reduction in the binding strength of the exon mimic-catalytic RNA 
interaction (even when using complementary 5’ exons). Also note that these results show 
that a dT-rA base pair at position –4 is tolerated. 
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Discussion 
 
We show that 5’ exon mimic chimeras can contain normal phosphodiester 
backbones and still be substrates in the suicide inhibition and reverse cyclization 
reactions. These non-modified chimeras, however, are less effective substrates in the 
suicide inhibition and reverse cyclization reaction, as compared to the N3’→P5’ 
phosphoramidates previously used (19, 43). This is not unexpected, as the 
phosphoramidate-containing duplexes are significantly more thermodynamically stable 
than the unmodified chimera-containing duplexes (53). In addition, the modified 
duplexes are expected to more closely resemble A-form RNA duplexes as compared with 
the unmodified duplexes (53), thus maintaining helix geometry more amenable to tertiary 
interactions.  
The combinatorial approach developed in this work identifies substrate sequences 
that are able to effectively compete with a pool of all available sequences for being a 
substrate in the suicide inhibition and reverse cyclization reactions. The resultant 
sequences, therefore, are not a comprehensive list of all possible substrates, but rather 
those most able to compete for the 5’ IGS binding site for subsequent reactivity. Note, 
however, that this assay can detect very poor substrates as well, albeit rarely, as long as 
the rate of substrate dissociation is not substantially faster than the rate of chemistry. 
For those exon mimics that were obtained in the combinatorial assay, we could 
find no correlation between the number of times the exon mimics occur and their 
observed rate constants. This indicates that the rate of chemistry is likely not the limiting 
factor in determining how often the 5’ exon mimics occur (for those that are obtained in 
the assay). The number of occurrences of each exon mimic does appear to correlate with 
the binding strength of the mimics, although there are exceptions. These exceptions likely 
stem from limitations of the binding assay itself. Analyzing exon mimic binding using the 
ribozyme approximates the actual binding that occurs when the exon mimic has to 
compete with the endogenous 5’ exon in the combinatorial assay. Note, however, that we 
do have one example of a representative exon mimic, d(AGCAC)rU), that binds the 
ribozyme but does not react in the assay. Therefore, it is expected that either the rate of 
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chemistry or the strength of substrate binding can be a limiting factor in whether a 
particular exon mimic is detected in the combinatorial assay. 
 
Sequence Specificity of Suicide Inhibition  
As expected, the native 5’ exon sequence, d(ATGAC)rU, occurred most often in 
the suicide inhibition reaction at 4 and 15 mM MgCl2, indicating that the native sequence 
is the most effective suicide inhibitor and that the reactions were run under reasonably 
stringent conditions. However, a number of other sequences are also permitted. In fact, 
all five randomized exon positions tolerate nucleobases not present in the native 5’ exon. 
In general, the requirement for even moderate sequence specificity decreases as you get 
further away from the reaction site (position –1 of the 5’ exon), with the specificity 
decreasing considerably at positions –5 and –6. In addition, it appears that a wobble pair 
is an acceptable substitute for Watson-Crick base pairs at positions –2 and –3. The 
binding data (Table 3.4) and reactivity data (Table 3.5) using representative hexamers 
show that the 5’ exon sequences obtained in the combinatorial assay are indeed specific 
substrates in the suicide inhibition reaction. Therefore, similar to the specificity of trans-
splicing and reverse splicing reactions for Tetrahymena ribozymes (56-60), the sequence 
specificity of the suicide inhibition reaction for the P.  carinii intron is not high. 
The physiological environment within which the group I intron-catalyzed self-
splicing reaction takes place is largely unknown. Reports indicate that the amount of free 
magnesium in a cell is at or below 1 mM (61, 62). We have previously shown that this is 
not enough magnesium for the intron to fold and catalyze the self-splicing reaction in 
vitro (17, 43). There is evidence, however, that proteins can aid in the folding of introns 
(63), which diminishes the need for a high salt environment in the cell. In our assays, a 
greater diversity of sequences (and of positional mismatches) is permitted at higher salt. 
One possible explanation for this is that the differential stability of the various 5’ exon 
mimic-IGS helices decreases at increased MgCl2 concentration. Extrapolating these 
results to physiological concentrations of MgCl2 suggests that a low salt environment 
(perhaps containing RNA folding chaperones) would naturally facilitate IGS-mediated 
reactions with higher sequence specificity than reported here. 
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It has been noted that one possible way to enhance specificity is by weakening the 
strength of the 5’exon-IGS interaction, for example by mismatch incorporation, such that 
the discrimination threshold increases between similar sequences (54, 64). As we see 
here, mismatch incorporation does not always lead to weaker binding [compare 
d(ATGAT)rU and d(ATGAC)rU in Table 3.4]. Nevertheless, the MgCl2 concentration 
dependent studies do appear to confirm that weaker binding (at 4 mM relative to 15 mM 
MgCl2) results in increased specificity.  
 
Sequence Specificity of Reverse Cyclization 
Using the combinatorial approach, we have shown that the reverse cyclization 
product is actually a combination of products. The sequence dependence of the reverse 
cyclization reaction was of interest because it was previously shown with a Tetrahymena 
intron system that reverse cyclization substrates, which are also 5’ exon mimics, can be 
as short as a dinucleotide, indicating that the 5’ exon mimics might base pair with only 
relatively short regions of the IGS (32, 46, 47). The results (Table 3.2) for the P. carinii 
intron show there is a functional advantage to having all or most of each reverse 
cyclization substrate complementary to the corresponding IGS region. In addition, the 
sequence specificity for the suicide inhibition and the reverse cyclization reactions are 
substantially dissimilar. For example, 58% of the substrates in the reverse cyclization 
reaction are the native 5’ exon sequence, while in the suicide inhibition reaction just 13% 
of the substrates are the native sequence (each at 15 mM MgCl2). In addition, unlike 
suicide inhibition substrates, reverse cyclization substrates do not require a dG at either 
position –4 or –5 of the exon. One possible explanation for this is that complementary 
base pairing at position –4 (and other positions) is beneficial in the reverse cyclization 
reaction because it enhances base pairing stability, while in the suicide inhibition reaction 
this position is additionally involved in critical tertiary interactions. Apparently, factors 
that govern the molecular recognition of the IGS for the 5’ exon in the reverse cyclization 
and suicide inhibition reactions are not identical, indicating a dynamic use of the IGS 
between the two reactions. 
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Molecular Recognition 
In all assays conducted, the permissibility of non-pairing mismatches increases 
the farther away from the reactivity center (exon position –1) that the mismatch occurs, 
with a marked decrease after position –4. This supports previous experimental data that 
shows nearly all of the tertiary stability of this molecular interaction occurs within the 
four 3’ bases of the 5’ exon-IGS interaction (19). Thus, the occurrence of base pairs at 
positions –5 and –6 may serve to simply increase the stability of the P1 helix in 
preparation for subsequent tertiary interactions during the docking stage(s) of folding. In 
addition, replacing Watson-Crick base pairs with wobble base pairs at positions –2, –3, 
and –6 does not significantly interfere with the overall binding of the mimic to the 
catalytic core of the intron. This was not anticipated because wobble pairs have some 
different accessible functional groups for tertiary interactions than Watson-Crick pairs 
(30). Apparently, these structural differences at these positions do not alter the ability of 
the resultant P1 helices to form tertiary interactions with the catalytic core of this intron.  
The decrease in occurrence of dG at exon position –4 in the suicide inhibition 
assay as the MgCl2 concentration increases directly correlates with an increase in the 
occurrence of dG at position –5. The binding assays, where a dG at position –5 rescues 
lost binding that occurs in the absence of dG at position –4, shows that this is not a 
random trend. In addition, P1 helices with dC-rC or dG-rG mismatches at position –4 are 
not able to stably dock into the catalytic core of the ribozyme. This suggests that there is 
an absolute requirement for a base pair at the –4 exon-IGS position. In cases where 
positional rescue of binding occurs, it is likely that the dG at position –5 base pairs with 
the corresponding position –4 of the IGS, leaving the nucleobase at exon position –4 as a 
single nucleotide bulge in the P1 helix (Figure 3.5). The overall stability that results from 
having a base pair at position –4 appears to be strong enough to dominate the disruption 
of base pairs at exon positions –3 and –5. It is interesting to note that the corresponding 
position in an Azoarcus intron likely participates in a structurally important A-minor 
tertiary motif (65). Perhaps in support of this, A-minor motifs appear to 
thermodynamically favor canonical base pairs over base pair mismatches (66), which is 
the same trend we see at the –4 position.  
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 Interestingly, the exon mimic d(AGCAC)rU does not react in the suicide 
inhibition assays (exon mimic #7 in Table 3.5), but does bind the ribozyme (exon mimic 
#7 in Table 3.4). Apparently, binding alone is not enough to specify reactivity, as local 
and global structure of the P1 helix also plays a role in determining reactivity (27). This 
is further supported with the 5’ exon mimic d(ATGAT)rU (exon mimic #6), which binds 
very tightly to the ribozyme, but its extent of reaction is relatively low.  
We show that IGS-modified P. carinii ribozymes do favor binding to 5’ exon 
mimics that are complementary to their particular IGS. However, the strength of the 
overall binding of the exon to the ribozyme can change considerably even though the 5’ 
exon-IGS helices are complementary at exon positions –2 through –6. In the case of the 
rPC-oppo ribozyme, this change in overall binding stability is primarily due to a 
reduction in tertiary stability (approximately 1.5 kcal/mol). This indicates that the 
ribozyme likely forms tertiary interactions with only specific base pairs at certain P1 
helix positions, in contrast to that reported with the Tetrahymena ribozyme (27, 67). One 
possible source of base pair specific tertiary interactions is Type I A-minor motifs (68), 
although there is no direct evidence that such a motif occurs here. 
It does not appear that the large sequence diversity of 5’ exons obtained in the 
combinatorial suicide inhibition and reverse cyclization assays can be explained by the 5’ 
exons misaligning (or slipping) on the IGS (55, 69), although in a few cases it could be 
occurring. The different cyclization products obtained (and hence different sites of 
reverse cyclization), however, can be explained by different regions of the 5’ end of the 
spliced intron base pairing with the IGS (Figure 3.1). Note that the cyclization reaction is 
similar to the self-splicing reaction in that the reaction substrates bind to the IGS (70). 
The forward and reverse cyclization data reveal that in three cases (Figure 3.6) the 
cyclization sites in the exons contain three contiguous pyrimidines that possibly pair with 
the G-rich end of the IGS. In these cases the cyclization junction is likely to be situated 
along the IGS at the same position as the self-splicing junction. The positioning of the 
exon cyclization junction along the IGS is not obvious for the fourth case, and so may not 
utilize the same positioning as the self-splicing junction. The data also reveals that 
substrate slipping occurs in the P9.0 helix, as either of the last two guanosines can act as 
cyclization nucleophiles. This is possible because either of these guanosines can bind the 
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G-binding site, while upstream bases are able to form a P9.0 helix. Implicit then is the 
possibility that either guanosine can act as the terminal guanosine of the intron during the 
second step of self-splicing under the reaction conditions used here. 
All of the above results show that the combinatorial assay developed in this report 
has proven useful for gaining a more fundamental understanding of the molecular 
recognition properties of IGS-mediated reactions. 
 
Implications 
Previous reports have shown that oligonucleotides that mimic the 5’ exon of the 
P. carinii rRNA group I intron are suicide inhibitors of the self-splicing reaction in vitro 
(43). Such inhibitors are novel in that they specifically exploit the tertiary interactions of 
the structured RNA. This was coined Binding Enhancement by Tertiary Interactions 
(BETI) (45, 58). This strategy was developed to potentially alleviate the problem of non-
specific binding, which appears to be a factor in using conventional antisense approaches 
(64, 71, 72). As a general rule, these results show that BETI (and more specifically 
suicide inhibition) likely will suffer from the same problem, although perhaps to a lesser 
degree: mismatches can be tolerated when short helices are stabilized by tertiary 
interactions (unless the mismatches severely disrupt tertiary interactions). 
RNA targeting strategies such as BETI (45, 58) and mRNA repair (5, 6) rely on 
tertiary interaction formation between the catalytic RNA enzyme and its substrate (after 
base pairing). This report shows that the strength of these tertiary interactions can depend 
on the presence of certain base pairs at certain positions along the catalytic RNA-
substrate helix, which could effectively limit the choice of targets that the catalytic RNA 
can act on. This could, however, also increase the specificity of the catalytic RNA, as the 
strength of the catalytic RNAs binding to similar, but undesired targets could be 
decreased. 
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Table 3.1 Suicide Inhibitors of the Self-Splicing Reaction 
A 
Number of Occurrences at each MgCl2 Concentration
4 mM  15 mM
MgCl2 -6 -5 -4 -3 -2 -1 MgCl2
7 (22%) d(A T G A C) rU 4 (13%)
2 d(C T G A C) rU 0
0 d(G T G A C) rU 1
0 d(T T G A C) rU 1
2 d(T G G A C) rU 1
0 d(A G G A C) rU 1
2 d(T A G A C) rU 0
1 d(G A G A C) rU 0
0 d(C A G A C) rU 1
3 d(A T G G C) rU 3
2 d(T T G G C) rU 1
0 d(G T G G C) rU 1
1 d(C C G G C) rU 0
1 d(A C G G C) rU 0
1 d(T C G G C) rU 0
0 d(T G G G C) rU 1
0 d(C G G G C) rU 1
2 d(T A G G C) rU 0
1 d(A A G G C) rU 1
0 d(T T G T C) rU 1
2 d(T T G A T) rU 0
0 d(G T G A T) rU 1
0 d(A T G A T) rU 1
2 d(T G G A T) rU 1
0 d(T A G A T) rU 1
0 d(T G T A T) rU 1
1 d(C T G G T) rU 0
1 d(T G C G C) rU 0
1 d(C G T A C) rU 0
0 d(A G T A C) rU 1
0 d(C G C G C) rU 1
0 d(T G T G C) rU 1
0 d(G G C T C) rU 1
0 d(T G A C C) rU 1
0 d(A G T G C) rU 1
0 d(T T G A A) rU 1
32 Total  30 Total
B        
 3’r(U A C U G G)5’  
C        
Percent Occurrence in 4 mM MgCl2        
 A37 T53 G94 A59 C84 rU100  
 T44 A19 C3 G41 T16   
 C16 C9 T3     
 G3 G19      
        
Percent Occurrence in 15 mM MgCl2     
 A40 T50 G77 A53 C80 rU100  
 T37 G40 T13 G37 T17   
 G13 A10 C7 T7 A3   
 C10  A3 C3    
(A) Suicide inhibitors obtained from the combinatorial assays 
(written 5’ → 3’). The number of occurrences for each 
sequence is indicated in the left column for reactions at 4 mM 
MgCl2 and in the right column for reaction at 15 mM MgCl2. 
Note that position –1 is RNA and was not randomized, while 
positions –2 through –6 are DNA and were randomized. The 
numbering system for the inhibitor positions is shown above 
the sequences. Note that the inhibitors are 5’ exon mimics. (B) 
Sequence of the IGS of the rP-h intron (and the rPC 
ribozyme). (C) The percent occurrence of the four nucleobases 
at each position. Note that the percent occurrences are 
different for the two MgCl2 concentrations. 
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Table 3.2 Reverse Cyclization Products 
          Exon Substrate                               Intron Splice Site 
A 
  -6    -5 -4    -3 -2     -1 
d(A    T G     A     C)   rU- - - - - - - - - - - -UCUGAG ______
d(A    T G     A C)   rU- - - - - - - - - - - -UCUGAG ______
d(A    T     G     A     C)   rU- - - - - - - - - - - -UCUGAG ______
d(A    T     G     A     C)   rU- - - - - - - - - - - -UCUGAG ______
d(A    T   G     A     C)   rU- - - - - - - - - - UUCUGAG ______
d(A    T     G     A     C)   rU- - - - - - - - CCUUCUGAG ______
d(A    T     G     A     C)   rU- - - - - - - - CCUUCUGAG ______
d(A    T     G     A     C)   rU- - - - - - - - CCUUCUGAG ______
d(A    T     G     A     C)   rU- - - - - - - - CCUUCUGAG ______
d(A    T     G     A     C)   rU- - - - - -CACCUUCUGAG ______
d(A    T     G     A     C)   rU- - - - - -CACCUUCUGAG ______
d(A    T G     A     C)   rU- - - - - -CACCUUCUGAG ______
d(A    T     G     A     C)   rU- - - - - -CACCUUCUGAG ______
d(A    T   G     A     C)   rU- - - - - -CACCUUCUGAG ______
d(C    A G     G     C)   rU - - - - - - - - - - - UCUGAG ______
d(C    A     G     G     C)   rU - - - - - - - - - - - UCUGAG ______
d(C    A     G     G     C)   rU - - - - - - - - - - - UCUGAG ______
d(A    A     G     A     T)   rU - - - - - - - - - - - UCUGAG ______
d(A    A     G     A     T)   rU - - - - - - - - - - - UCUGAG ______
d(A    A     G     A     T)   rU - - - - - - - - - - - UCUGAG ______
d(T    G  T     A     C)  rU - - - - - - - - - - - UCUGAG ______
d(T    G  G     A     C)  rU- - - - - -CACCUUCUGAG ______
d(T    G  G     T     C)  rU- - - - - -CACCUUCUGAG ______
d(A    T      A     A     C)  rU- - - - - -CACCUUCUGAG ______
 
B 
3’r(U   A   C     U    G    G)5’
C   
   A75  T62.5  G92  A83   C87.5  rU100    
   T12.5 G25   T4   G12.5  T12.5
   C12.5 A12.5  A4   T4   
(A) Reverse cyclization products (written 5’ → 3’) of the 
combinatorial assay at 15 mM MgCl2 (24 total). The dashed 
lines represent a single phosphodiester bond. The solid lines 
represent nucleobase continuation within the intron. The 
numbering system for exon substrate positions is indicated 
above the sequences. Note that position –1 is RNA and was 
not randomized, while positions –2 through –6 are DNA and 
were randomized. (B) Sequence of the IGS of the rP-h intron 
(and the rPC ribozyme). (C) The percent occurrence of each 
nucleobase at each exon position.  
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Table 3.3 Cyclization of the rP-h Intron 
 
3’ end of intron   ligated to   5’ end of intron 
 
______ GUG- - - - - - - - - - - - - -UCUGAG ______
______ GUG- - - - - - - - - - - - - -UCUGAG ______
______ GUG- - - - - - - - - - - - - -UCUGAG ______
______ GUG- - - - - - - - - - - - - -UCUGAG ______
______ GUG- - - - - - - - - - - - - -UCUGAG ______
______ GUG- - - - - - - - - - - - - -UCUGAG ______
______ GUG- - - - - - - - - - - - - -UCUGAG ______
______ G - - - - - - - - - - - - - - - -UCUGAG ______
______ G - - - - - - - - - - - - - - - -UCUGAG ______
______ GUG- - - - - - - - - - - - - - - - UGAG ______
______ G - - - - - - - - - - CACCUUCUGAG ______
 
Shown are the cyclization junctions, 
which encompass the 3’ end and the 5’ 
end of the intron ligated together. The 
sequences are written in the 5’ → 3’ 
direction. The dashed lines represent a 
single phosphodiester bond. The solid 
lines represent nucleobase continuation 
within the intron. 
 
 45 
 Table 3.4 Thermodynamic Parameters for Representative Hexamers Binding to rPC and to r(GGUCAU) in H15Mg Buffera
 Binding to rPC  Binding to r(GGUCAU)  Tertiary Stability 
Exon Mimic 
              -6-5-4-3-2-1 
Kd, TOTAL     
(nM)b
-ΔGO37, TOTAL 
(kcal/mol)c
 Kd, BP           
(mM)c
-ΔGO37, BP 
(kcal/mol)b
 -ΔΔGO37, BETId 
(kcal/mol)e
K2f
             r(AUGACU) 1.79 ± 0.27 12.41 ± 0.10  0.51 ± 0.06 4.67 ± 0.07  7.74 ± 0.12 286,000 
 (5.21 ± 1.4)g (11.75 ± 0.19)  (0.32 ± 0.04) (4.96 ± 0.07)  (6.79 ± 0.20) (61,000) 
#1        d(ATGAC)rU* 62.6 ± 10.3 10.22 ± 0.11  2.35 ± 0.69 3.73 ± 0.16   6.49 ± 0.19 37,600 
  (61.1 ± 7.0)  (10.2 ± 0.08)  (4.072 ± 1.208) (3.39± 0.16)  (6.84 ± 0.18) (66,600) 
#2 Pr2-d(ATGAC)rU*  139.5 ± 0.95   9.72 ± 0.01  NQh NQ  NDi ND 
#3        d(GTGAC)rU*  109.9 ± 17.3    9.87 ± 0.11  2.73 ± 0.97 3.64 ± 0.19  6.23 ± 0.21 24,900 
#4        d(AGGAC)rU*  158.3 ± 26.9   9.65 ± 0.11  3.65 ± 1.73 3.46 ± 0.24  6.19 ± 0.26 23,000 
#5        d(ATGGC)rU*  129.8 ± 23.5   9.77 ± 0.12  3.93 ± 0.62 3.41 ± 0.09  6.36 ± 0.15 30,300 
#6        d(ATGAT)rU  38.83 ± 1.15  10.5 ± 0.02  3.66 ± 0.58 3.46 ± 0.09  7.06 ± 0.09 94,200 
#7        d(AGCAC)rU  136.6 ± 13.7   9.74 ± 0.06  3.75 ± 1.05 3.44 ± 0.15  6.30 ± 0.16 27,500 
#8        d(ATCAC)rU - j -  3.61 ± 1.02 3.46 ± 0.15  ND ND 
#9        d(CGCGT)rU - -  3.11 ± 0.63 3.56 ± 0.11  ND ND 
#10      d(CGTCA)rU - -  3.90 ± 1.13 3.42 ± 0.16  ND ND 
aH15Mg buffer consists of 50 mM Hepes (25 mM Na+), 15 mM MgCl2, and 135 mM KCl at pH 7.5. 
Nucleobases that are bold and underlined represent deviations from the native 5’ exon sequence 
d(ATGAC)rU. An asterisk (*) indicates oligonucleotides that occur in the combinatorial assay. bKd, TOTAL 
was measured by a competition band-shift electrophoresis assay and -ΔGO37, BP was measured by thermal 
denaturation analysis. The error is the standard deviation of the measurements. cCalculated from -ΔGO37 = 
RTln(Kd) where R = 0.001987 kcal mol-1 K-1 and T=310 K, using more significant digits than listed in this 
table. dBETI represents Binding Enhancement by Tertiary Interactions. eFree energy increment from 
tertiary interactions calculated from the difference in -ΔGO37 values [(-ΔGO37, TOTAL) -(-ΔGO37, BP)]. The 
-ΔΔGO37, BETI error was calculated from the square root of the sum of the squares of each individual -ΔGO37 
error. fThe K2 values were calculated by dividing Kd, BP by  Kd, TOTAL, using Kd values containing more 
significant digits than those listed in this table. gValues in parentheses are from reference 6. hValues were 
not quantifiable (NQ) due to multiphasic transitions. iND represents values that are not determinable. j A 
dash (-) indicates no measurable binding (Kd > 1.5 μM).  
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Table 3.5 Kinetics of Representative Exons in the Suicide Inhibition and Reverse Cyclization Reactions as a Function of MgCl2 
Concentrationa
                                                    Suicide Inhibition                                  Reverse Cyclization 
 4 mM MgCl2 15 mM MgCl2 4 mM MgCl2 15 mM MgCl2
 
Exon Mimics 
 
kobs, (min-1)b
Relative 
Extent of 
Reaction
c
 
kobs, (min-1) b
Relative 
Extent of 
Reactionc
 
kobs, (min-1) b
Relative 
Extent of 
Reactionc
 
kobs, (min-1) b
Relative 
Extent of 
Reaction
c
               r(AUGACU) 0.081 ± 0.031 100.0% 0.145 ± 0.053 6.3% 0.095 ± 0.060 35.3% 0.169 ± 0.062 100.0% 
#1           d(ATGAC)rU* 0.013 ± 0.003 62.5% 0.014 ±  0.002 43.8% 0.007 ± 0.002 23.5% 0.051 ± 0.007 23.5% 
#2   Pr2-d(ATGAC)rU* - d - - - - - - - 
#3           d(GTGAC)rU * 0.019 ± 0.003 37.5% 0.019 ± 0.003 31.3%  NQe  <3% 0.042 ± 0.009 17.6% 
#4           d(AGGAC)rU * 0.012 ± 0.002 9.4% 0.008 ± 0.002 21.9%  NQ  <3% 0.020 ± 0.001 5.9% 
#5           d(ATGGC)rU * 0.018 ± 0.001 62.5% 0.039 ± 0.011 31.3% 0.009 ± 0.001 11.8% 0.039 ± 0.003 23.5% 
#6           d(ATGAT)rU   0.031 ± 0.005  25.0% 0.030 ± 0.016 9.4% 0.018 ± 0.002 5.9% NQ  <3% 
#7           d(AGCAC)rU NQ  <3% - - -  - NQ  <3% 
#8           d(ATCAC)rU - - - - - - - - 
#9           d(CGCGT)rU - - - - - - - - 
         
aBuffers consist of 50 mM Hepes (25 mM Na+), 4 mM or 15 mM MgCl2, and 135 mM KCl at pH 7.5. 
Nucleobases that are bold and underlined represent deviations from the native 5’ exon sequence 
d(ATGAC)rU. An asterisk (*) indicates oligonucleotides that occur in the combinatorial assay. bThe error 
is the standard deviation of the measurements. cThe extent of reaction for the suicide inhibition reactions 
are reported relative to that obtained with r(AUGACU) at 4 mM MgCl2 (actual extent of reaction = 32%). 
Similarly, the extent of reaction for the reverse cyclization reactions are reported relative to that obtained 
with r(AUGACU) at 15 mM MgCl2 (actual extent of reaction = 17%). The relative extent of reaction is 
calculated by dividing the actual extent of reaction for each oligonucleotide by that for r(AUGACU) and 
multiplying by 100. dA dash (-) indicates no measurable activity. eNQ represents measurements that are 
not quantifiable due to inconsistent results with low product formation. 
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Table 3.6 Thermodynamic Parameters for Representative Exon Mimics Binding to Ribozymes and to IGS Mimics in 
 Binding to Ribozyme  Binding to IGS Mimic  Tertiary Stability 
Exon Mimic 
    -6-5-4-3-2-1 
Kd, TOTAL      
(nM)b
-ΔGO37, TOTAL 
(kcal/mol)c
 Kd, BP          
(mM)c
-ΔGO37, BP 
(kcal/mol)b
 -ΔΔGO37, 
BETI
d 
(kcal/mol)e
K2f
 
 rPC  r(GGUCAU)   
  d(ATGAC)rUg 151.3 ± 10 9.67 ± 0.05  2.24 ± 0.66 3.76 ± 0.16  5.91 ± 0.17 14,800 
d(ATCAC)rU - h -  - -  - - 
d(CGTCA)rU - -  - -  - - 
         
 rPC-CtoG  r(GGUGAU)   
d(ATGAC)rU - -  - -  - - 
d(ATCAC)rU 274 ± 25.3 9.31 ± 0.06  3.69 ± 1.47 3.45 ± 0.21  5.86 ± 0.22 13,500 
d(CGTCA)rU - -  - -  - - 
         
 rPC-oppo  r(GUGACG))   
d(ATGAC)rU - -  - -  - - 
d(ATCAC)rU - -  - -  - - 
d(CGTCA)rU 1130 ± 47 8.43 ± 0.03  1.35 ± 0.20 4.07 ± 0.08  4.37 ± 0.09 1200 
         
aH15Mg buffer consists of 50 mM Hepes (25 mM Na+), 15 mM MgCl2, and 135 mM KCl at pH 7.5. 
Nucleobases that are bold and underlined represent deviations from the native 5’ exon sequence 
d(ATGAC)rU. bKd, TOTAL was measured by a direct band-shift electrophoresis assay with 
r(AUGACU) and -ΔGO37, BP was measured by thermal denaturation analysis. The error is the standard 
deviation of the measurements. cCalculated from -ΔGO37 = RTln(Kd) where R = 0.001987 kcal mol-1 
K-1 and T=310 K, using more significant digits than listed in this table. dBETI represents Binding 
Enhancement by Tertiary Interactions. eFree energy increment from tertiary interactions calculated 
from the difference in -ΔGO37 values [( -ΔGO37, TOTAL) - ( -ΔGO37, BP)]. The -ΔΔGO37, BETI error was 
calculated from the square root of the sum of the squares of each individual -Δ GO37 error. fThe K2 
values were calculated by dividing Kd, BP by  Kd, TOTAL, using Kd values containing more significant 
digits than those listed in this table. gDissociation constants (Kds) obtained through direct band-shift 
assays are typically 2.5 times larger than those obtained through the competitive band-shift assay (17, 
73).  hA dash (-) indicates no measurable binding (Kd > 1.5 μM).  
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Figure 3.1 Schematic Diagram of Self-Splicing and Cyclization (Steps A → E), Suicide 
Inhibition (Steps F → G), and Reverse Cyclization (Steps H → I). Addition of an 
exogenous exon substrate (N represents positional randomization) leads to both suicide 
inhibition and reverse cyclization products. Note that steps C and G are in competition, as 
they occur concurrently. Uppercase lettering and black lines represent the intron. 
Lowercase lettering and their associated lines with arrows represent the exons. The 
elongated region of the exon mimics is double lined. Tertiary interactions are represented 
by dots. RT-PCR primers Pr1, Pr2, Pr3 and Pr4 bind to the designated regions. Pr2* 
indicates that Pr2 and Pr2-d(ATGAC)rU can both act as RT primers even though neither 
are complementary to the target region for the cyclization. Note that, at least for the P. 
carinii intron, step B is also achieved through ribozyme-mediated hydrolysis in the 
absence of pG (as is the case throughout this study) (6). After step C, the intron sequence 
is shown in more detail. Positions that can act as cyclization nucleophiles are shown with 
white lettering on a dark gray background and the intron sites of cyclization are shown 
with black lettering on a dark gray background. The internal guide sequence (IGS) is 
5’GGUCAU3’.  
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Figure 3.2 Magnesium Dependence of the Suicide Inhibition (S.I.) and Reverse 
Cyclization (R.C.) Reactions. (A) A typical polyacrylamide gel of the reactions. Lanes 
0→15 show reactions using 1 nM radiolabeled 5’ exon mimic d(ATGAC)rU and 500 nM 
of rP-h in HXMg buffer [50 mM Hepes (25 mM Na+), 135 mM KCl, and X mM MgCl2 
(from 0 to 15) at pH 7.5]. Lanes A and B show reactions using 1 nM radiolabeled 5’ exon 
mimic Pr2-d(ATGAC)rU (27-mer) and 500 nM of rP-h in H4Mg (Lane A) or H15Mg 
(Lane B) buffer. All reactions were run for two hours, which allows maximum product 
formation. The sizes of the 27-mer, 52-mer, 350-mer, and 370-mer are approximate. (B) 
Graph of the MgCl2 concentration dependence for the suicide inhibition (open squares) 
and the reverse cyclization (solid circles) reactions shown above. Note that both reactions 
occur simultaneously and that the graph is an average of two reactions.  The standard 
deviations were typically below ten percent. 
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Figure 3.3 Competitive Binding Assay. Reactions run with d(ATGAC)rU in 50 mM 
Hepes (25 mM Na+), 15 mM MgCl2, and 135 mM KCl at pH 7.5. (A) A native 
polyacrylamide gel showing the partitioning of bound and free radiolabeled r(AUGACU) 
as a function of non-radiolabeled d(ATGAC)rU concentration. Reactions utilized 30 nM 
rPC ribozyme, 1 nM radiolabeled 5’ exon mimic r(AUGACU), and 5 to 1500 nM of the 
competitor d(ATGAC)rU. (B) Plot and curve-fit of the data in panel A. Note that the 
results in Table 3.4 are an average of two independent assays.  Refer to Table 3.4 for 
standard deviations. 
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Figure 3.4 Kinetic Analysis of Suicide Inhibition and Reverse Cyclization Reactions. 
Reactions run using 500 nM rP-h and 1 nM radiolabeled d(ATGAC)rU in 50 mM Hepes 
(25 mM Na+), 4 mM MgCl2, and 135 mM KCl at pH 7.5. (A) A polyacrylamide gel 
showing a time dependence assay of a typical suicide inhibition and reverse cyclization 
reaction, using d(ATGAC)rU as the substrate. Note that both reactions occur 
simultaneously. (B) Graph showing the plot and curve-fit for the suicide inhibition (open 
square) and reverse cyclization reactions (solid circle) in Panel A. Note that the results in 
the Table 3.5 are an average of two independent assays.  Refer to Table 3.5 for standard 
deviations. 
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Figure 3.5 Schematics of 5’ Exon Mimics Base Pairing with the IGS of the P. carinii 
Ribozyme. (a) The native 5’ exon, (b) the 5’ exon with a single G to C mutation at exon 
position –4, and (c) the 5’ exon with a G to C mutation at exon position –4 and a T to G 
mutation at exon position –5. The Kd values given are for the respective 5’ exon mimics 
binding to the IGS through base pairing and tertiary interactions (in 15 mM MgCl2). 
Exon positions –2 through –6 are deoxyribonucleotides. Note that the double mutant (c) 
rescues binding lost with the single mutant (b). 
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Figure 3.6 Schematics of the 5’ End of the Intron Base Pairing with the IGS Before 
Cyclization. These are three possible routes for the 5’ end of the intron binding to the G-
rich region of the IGS that are consistent with the data. The cyclization reaction is similar 
to the self-splicing reaction with the substrate binding to the IGS, allowing the free 3’OH 
on the 3’ G to attack at the –1 exon position. 
 
 
 
 
 
 
 
 
 
Copyright © Ashley Kirtley Johnson 
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CHAPTER FOUR - A Tetrahymena Group I Intron-Derived 
Ribozyme Catalyzes the Trans Excision-Splicing Reaction 
 
 
Introduction 
 
In the trans-excision splicing reaction (TES), a group I intron-derived ribozyme 
from the opportunistic pathogen P. carinii base pairs with an exogenous RNA substrate, 
excises a specific segment, and ligates the ends of the RNA substrate back together 
(Figure 4.1) (6).  The TES reaction has two reaction steps, initiated by adding substrate to 
the ribozyme.  The substrate forms a P1 helix with the IGS of the ribozyme.  This P1 
helix is positioned into the catalytic core by tertiary interactions.  The first nucleophilic 
attack occurs at the end of the P1 helix and results in 5’-splice site cleavage of the 
substrate.  The second nucleophilic attack occurs at the 3’-splice site between the insert 
and the 3’end of the substrate, resulting in TES product formation.  This TES reaction has 
been extensively studied with the P. carinii ribozyme (6, 20, 21), but to make this 
reaction more generally applicable, we tested whether another group I intron-derived 
ribozyme could perform the TES reaction.   
Exploration of intron self-splicing and the development of new group I intron-
derived ribozyme reactions has been predominately conducted using a group I intron 
from the ciliate Tetrahymena thermophila.  Therefore, we wanted to see if the 
Tetrahymena ribozyme could perform the TES reaction and if so, compare it to the P. 
carinii TES reaction.  Previous results have shown that the P. carinii and Tetrahymena 
ribozymes utilize a different array of tertiary interactions to dock the P1 helix into the 
catalytic core (17-19).  Since the TES reaction utilizes the P1 helix in the first 
nucleophilic attack, there may be differences in the ability of these two ribozymes to 
perform the TES reaction.   
Both the 5’ and 3’-splice sites in the Tetrahymena self-splicing reaction are 
susceptible to hydrolysis (41, 74, 75), although Tetrahymena ribozymes do not appear to 
catalyze ribozyme-mediated 5’-splice site cleavage as well as P. carinii ribozymes (6, 
76).  Ribozyme mediated cleavage by a free hydroxyl (from the buffer) at the 5’-splice 
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site in the substrate is the first step of the TES reaction (first nucleophilic attack shown in 
Figure 4.1.2).  Therefore, the ability of the Tetrahymena ribozyme to perform the TES 
reaction is suspected to be in part dependent on its ability to perform ribozyme-mediated 
5’-splice site cleavage.  This will be analyzed in this study. 
In this work, we show that the TES reaction is not specific to the P. carinii 
derived-ribozyme, but also occurs in a Tetrahymena-derived ribozyme. In our model 
system, the Tetrahymena TES reaction was performed with a 13-nucleotide substrate, 
excising one nucleotide from the center.  The TES reaction with the Tetrahymena 
ribozyme has lower optimized product yield and decreased observed rate constants for 
both the first and second steps of the reaction (optimized for yield), compared to the P. 
carinii ribozyme.  For additional comparison, two hybrid ribozymes were also tested: the 
Tetrahymena ribozyme with the P. carinii IGS and the P. carinii ribozyme with the 
Tetrahymena IGS.  The hybrid ribozymes allow us to separately compare the ability of 
the catalytic core of each ribozyme, as well as their specific native substrates, in 
performing the TES reaction.   
The results suggest that the TES reaction is a general group I intron-derived 
ribozyme reaction.  Both the sequence of the substrate (and hence the base paired P1 and 
P10 helices) and the characteristics of the individual ribozyme contribute to the accuracy 
and efficiency of the TES reaction.  Additionally, the ability of the ribozyme and 
substrate to allow ribozyme-mediated 5’-splice site cleavage appears to be particularly 
important for efficient TES product formation. 
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Methods 
 
Synthesis and Purification of Oligonucleotides 
 For these studies, four ribozymes were used: rT, which is transcribed from the L-
21 Tetrahymena plasmid (kindly provided by Douglas Turner, University of Rochester; 
Rochester, NY); rT-PC, which is the Tetrahymena ribozyme with the IGS from P. 
carinii; rPC, which is rP-8/4x from previous work (6); and rPC-T, which is the P. carinii 
ribozyme with the Tetrahymena IGS.  The ribozymes are diagramed in Figure 4.2.  The 
hybrid plasmids, pT-PC and pPC-T, were made by changing pT and pPC via site directed 
mutagenesis essentially as described (77).    The pT-PC plasmid was made using two 
rounds of site directed mutagenesis using the primer pairs 
CGACTCACTATAGAGGGAGGGAAAAGTTATC and 
GATAACTTTTCCCTCCCTCTATAGTGAGTCG for the first round and 
CACTATAGAGGGTCATAAAAGTTATCAGGC and 
GCCTGATAACTTTTATGACCCTCTATAGTG for the second round.  The pPC-T 
plasmid was made using two rounds of site directed mutagenesis using primer pairs 
CGACTCACTATAGATGGAGGGGAAAGCGGC and 
GCCGCTTTCCCCTCCATCTATAGTGAGTCG for the first round and 
CGACTCACTATAGACCTTTGGAGGGGAAAGCGGC and 
GCCGCTTTCCCCTCCAAAGGTCTATAGTGAGTCG for the second round.  The 
DNA primers were purchased from Integrated DNA Technologies, Inc. (Coralville, IA).  
The mutated plasmids were sequenced for confirmation (Davis Sequencing, University of 
California, Davis).   
The ribozyme plasmids were linearized in 50 μL reactions consisting of 8 μg 
plasmid and either 100 U of ScaI restriction enzyme (New England Biolabs, Beverly, 
Massachusetts) for the two Tetrahymena plasmids (pT and pT-PC) or 50 U of XbaI 
(Invitrogen, Grand Island, New York) for the two P. carinii plasmids (pPC and pPC-T).  
Linearization was confirmed by visualization on a 1% agarose gel.  The linearized DNA 
was purified using a QIAquick PCR Purification Kit (Qiagen, Valencia, CA) and eluted 
in water.  Run-off transcription was performed for two hours in 100 μL reactions 
consisting of 1 to 2 μg of linear DNA, 50 U of T7 RNA polymerase (New England 
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Biolabs), 40 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM DTT, 5 mM spermidine, 1 
mM rNTP mix, and 62.5 μg/mL BSA.  The ribozymes were purified using a Plasmid 
Midi-Kit (Qiagen) as described previously (6) or by the RNeasy purification kit (Qiagen).    
RNA oligonucleotides were purchased from Dharmacon Research, Inc. 
(Lafayette, CO).  Designated oligonucleotides were 5’ end radiolabeled and purified by 
polyacrylamide gel electrophoresis as described previously (17).  Oligonucleotide and 
ribozyme concentrations were calculated based on UV-absorption measurements using a 
Beckman DU 650 UV-Spectrophotometer (Beckman Coulter, Inc., Fullerton, CA). 
 
TES Reaction and Optimization   
 Reactions were performed in buffer consisting of 50 mM Hepes (25 mM Na+), 
135 mM KCl, and various concentrations of MgCl2.  The reactions were optimized for 
magnesium concentration (0-25 mM MCl2), ribozyme concentration (0-500 nM), and 
time dependence (1-180 min).  The optimized reaction conditions were: 100 nM rPC and 
15 mM MgCl2 for 30 min; 100 nM rPC-T and 4 mM MgCl2 for 60 min; 100 nM rT-PC 
and 8 mM MgCl2 for 40 min; and 200 nM rT and 10 mM MgCl2 for 90 min (see Table 
4.1).  In each case, the reaction conditions were optimized to give the greatest TES 
product yields.  The ribozyme mix (4 μL, including everything except the substrate) was 
preannealed at 60oC for five minutes and then allowed to slowly cool to 44oC.  Reactions 
were initiated by adding 1 μL of 5’-end radiolabelled substrate (CUCUCUGAAAGGU 
for rT and rPC-T; or AUGACUGCUC for rPC and rT-PC).  Reactions were run at 44oC 
for the optimized amount of time and stopped by adding 5 μL stop buffer (10 M urea, 3 
mM EDTA, and 0.1X TBE).  Reactions were denatured for 1 min at 90oC and run on a 
12% polyacrylamide/8 M urea gel.  The gel was dried under vacuum.  The bands were 
visualized and quantified on a Molecular Dynamics Storm 860 Phosphorimager.  All 
reactions were run at least twice.  Reactions were also attempted in the typical 
Tetrahymena Tris buffer consisting of 50 mM Tris base, 0.1 mM EDTA, and 10 mM 
NaCl, and also under typical Tetrahymena preannealing conditions of 30 min at 50oC. 
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Kinetic Studies 
 The observed rate constants for the TES reaction using each ribozyme were 
obtained under single-turnover ‘intron excess’ conditions.  In these experiments, 60 μL of 
ribozyme in appropriate buffer was preannealed at 60oC for five minutes and slowly 
cooled to 44oC.  The reactions were initiated by adding a 15 μL aliquot of 5’-end 
radiolabelled substrate (CUCUCUGAAAGGU for rT and rPC-T or AUGACUGCUC for 
rPC and rT-PC), bringing the final concentrations to 1 nM substrate and 100 nM (for rPC, 
rPC-T, rT-PC) or 200 nM (for rT) ribozyme.  A 5 μL aliquot was periodically removed 
and added to 5 μL stop buffer.  The reactants and products were separated on a 12% 
polyacrylamide/8 M urea gel.  The gel was dried under vacuum.  The bands were 
visualized and quantified on a Molecular Dynamics Storm 860 Phosphorimager.  The 
observed rate constants for the first reaction step (5’cleavage product plus TES product 
over time) and for the second step (TES product over time) were quantified essentially as 
described (17).  Rate constants were calculated with data from at least two independent 
time studies. 
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Results 
 
A new ribozyme reaction, the TES reaction (Figure 4.1), was recently reported 
(6).  In the development of the TES reaction, a P. carinii group I intron-derived ribozyme 
was used.  To determine if the TES reaction is specific to the P. carinii ribozyme or if it 
is more general to group I introns, the reaction was attempted in another group I intron 
derived ribozyme, the L21-Sca I Tetrahymena ribozyme (called rT in this study).  The rT 
ribozyme was chosen because it has been extensively studied in group I intron-derived 
ribozyme reactions (1, 5, 29, 39, 76, 78-80).  Studying the TES reaction using the 
Tetrahymena ribozyme also allows us to compare the two different group I intron-derived 
ribozymes.   
The TES reaction is initiated by adding substrate (10mer or 13mer in this study) 
to the ribozyme.  The ribozyme recognizes its substrate partially through base pairing 
(Figure 4.1.1).  The first nucleophilic attack (Figure 4.1.2) occurs at a G-U wobble pair at 
the end of the P1 helix and results in 5’-cleavage of the substrate, producing a 6mer 
intermediate.  Some of this intermediate does not perform the second nucleophilic attack 
and can be seen as a 6mer product in the reaction.  The TES product forms when the free 
3’-OH group on the 6mer intermediate performs the second nucleophilic attack at the 
splice site between the insert and the 3’end of the substrate (Figure 4.1.3).  This second 
nucleophilic attack results in TES product formation (9mer or 12mer in this study).   
 
A Tetrahymena Group I Intron-Derived Ribozyme Catalyzes the TES Reaction  
As shown in Figure 4.3, the Tetrahymena ribozyme (rT) can catalyze the TES 
reaction, forming a 12mer product.  The TES reaction with the rT ribozyme was 
optimized for ribozyme concentration, MgCl2 concentration, and time dependence.  A 
representative gel and graphs of the averaged data are seen in Figure 4.3.  The optimum 
ribozyme (rT) concentration range is from 50-300 nM, with loss of product seen at higher 
concentrations (suspected to be due to additional reactions).  Subsequent reactions were 
conducted using 200 nM rT ribozyme, although 100 nM rT appears to work just as well.  
The optimum MgCl2 concentration is from 4-10 mM, and we ran subsequent reactions at 
10 mM MgCl2.  The optimum reaction time for the rT TES reaction is from 45-90 
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minutes, and we ran the subsequent reactions for 90 minutes.  The reaction was not 
optimized for rate, but was optimized for product yield.   
The optimum TES reaction with the P. carinii ribozyme (rPC) was recently 
published (6), but reactions were repeated here for comparison (Figure 4.4).  The rPC 
ribozyme appears to have a similar optimum ribozyme concentration range (30-200 nM) 
compared to that of rT.  The two ribozymes appear to differ the most with their optimum 
MgCl2 concentration range and time dependence.  The rT reaction is optimum at MgCl2 
concentrations as low as 4 mM (Figure 4.3.B), whereas the rPC ribozyme requires at least 
15 mM MgCl2 (Figure 4.4.B).  The rPC TES reaction is much faster, completed in less 
than 5 minutes (Figure 4.4.C).  Whereas, the rT TES reaction takes up to 45 minutes to 
reach its optimum yield (Figure 4.3.C).     
In the literature, P. carinii ribozyme reactions are typically performed in Hepes 
buffer, whereas Tetrahymena ribozyme reactions are typically performed in Tris buffer.  
Therefore, the Tetrahymena TES reaction was conducted in both buffers, and gave 
approximately the same product yields.  Therefore, all the reactions for this study were 
conducted in the P. carinii Hepes buffer.  In addition, the typical pre-annealing 
conditions for the Tetrahymena ribozyme are also different from the conditions for the P. 
carinii ribozyme.  Studies have shown that the Tetrahymena ribozyme requires 30 
minutes at 50oC for complete folding and maximum activity (76), whereas the P. carinii 
ribozyme only requires 5 minutes at 60oC.  The Tetrahymena ribozyme was pre-annealed 
under both conditions and gave the same product yield.  Therefore, all the reactions were 
run under the annealing conditions of 5 minutes at 60oC. 
 
The Tetrahymena Ribozyme does not Perform TES as well as the P. carinii Ribozyme 
The TES reaction can be evaluated based on the extent of reaction product 
formed.  The maximum amount of TES product from optimum reactions with rPC and rT 
is compared in Table 4.1.  The rPC ribozyme produces more TES product than rT, giving 
an average yield of 68.5±4.4%. The rT ribozyme produces 3-fold less TES product 
compared to the rPC, giving an average yield of 19.1±11.5%.  The standard deviation is 
high because the Tetrahymena ribozyme exhibits marked variability in its reactivity from 
different syntheses.  This variability has been noted in the literature (76).   
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 Another way to analyze the Tetrahymena and P. carinii TES reactions is to 
compare the observed rate constants, kobs, for each ribozyme reaction.  The time studies in 
Figure 4.3.C and Figure 4.4.C were used to calculate the observed rate constant for TES 
product formation.  The observed rate constant for the first step of the TES reaction is 
calculated as the sum of 5’-cleavage product (6mer) and TES product over time, as the 
TES product necessarily underwent the first step.  The observed rate constant for the 
second step of the TES reaction is calculated as the amount of TES product over time 
(represented by closed circles on the graphs in Figure 4.3.C and 4.4.C).   
For the P. carinii ribozyme, the kobs is 5.0 min-1 for the first step and 3.2 min-1 for 
the second step.  The kobs values for the Tetrahymena ribozyme are 70-fold lower for both 
steps of the reaction compared to the P. carinii ribozyme.  The kobs for Tetrahymena 
ribozyme is 0.07 min-1 for the first step and 0.05 min-1 for the second step.  The first 
nucleophilic attack of the TES reaction, 5’-splice site cleavage (Figure 4.1.2), appears to 
be much slower for the rT ribozyme compared to rPC.  This is not surprising since the rT 
ribozyme typically depends on exogenous G to perform the first nucleophilic attack (5, 
39, 76, 81).  Also, to keep the reactions consistent, all the reactions were performed under 
the optimum pre-annealing conditions for the P. carinii ribozyme.  Both conditions were 
shown to give the same amount of TES product for the rT reactions.   
 
Hybrid Tetrahymena and P. carinii Ribozymes 
Since group I intron-derived ribozymes recognize substrates through tertiary 
interactions (39, 77) in addition to base pairing, we analyzed whether the native P1 and 
P10 sequences in either the P. carinii or Tetrahymena intron would effect the ability of 
the ribozyme to perform the TES reaction.  Additionally, we wanted to analyze whether 
differences in the P. carinii and Tetrahymena reactions were due to fundamental 
differences in the catalytic core of the ribozymes, or whether they were due to the 
different IGS sequences.  Therefore, two hybrid ribozymes were analyzed to observe the 
influence the substrate sequence and the specific ribozyme has on the TES reaction.  The 
two hybrid ribozymes are rPC-T, which is the P. carinii ribozyme with the Tetrahymena 
IGS (Figure 4.2.B); and rT-PC, which is the Tetrahymena ribozyme with the P. carinii 
IGS (Figure 4.2.D).     
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 Optimization of the Hybrid P. carinii Ribozyme with the Tetrahymena IGS and 
Comparison to the P. carinii Ribozyme 
The rPC-T ribozyme is the P. carinii ribozyme with the Tetrahymena IGS (Figure 
4.2.B).  A representative optimization gel and graphs of averaged data are shown in 
Figure 4.5.  The yield-optimized reaction conditions are 100 nM rPC-T and 4 mM MgCl2 
with a reaction time of 60 minutes.  The optimum conditions for the rPC-T TES reactions 
differ from the rPC reaction conditions most noticeably in the narrow range of optimum 
ribozyme and MgCl2 concentrations, as well as substantially longer reaction times to 
obtain maximum yields.  The rPC-T requires much less MgCl2, 4mM versus 15 mM for 
rPC.  Also, the rPC reaction is complete in less than 5 minutes, whereas the rPC-T 
reaction takes almost an hour.  Simply by changing the IGS sequence (rPC to rPC-T), the 
optimum reaction conditions the hybrid P. carinii ribozyme change substantially from the 
native ribozyme.  In addition, the rPC-T optimum conditions are more similar to 
Tetrahymena ribozyme conditions.  Apparently, the IGS sequence markedly influences 
the reaction dynamics.     
The rPC-T reactions also produce substantial amounts of unidentified side 
products.  In the rT TES reaction run with the same 13mer substrate, these products are 
not nearly as prevalent (Figure 4.3, all lanes).  Apparently, there is something specific 
regarding the Tetrahymena ribozyme that prevents such side products when reacted with 
the same substrate.  Indeed, it is likely that each ribozyme has evolved ways of 
preventing cryptic site reactions that are specific to the sequence of its own substrate.         
The rPC-T TES reaction gives 25.6 ± 1.3% 12mer TES product.  This is 
approximately a third less product than what is produced by the rPC ribozyme with its 
native substrate.  Simply by changing the IGS of the P. carinii ribozyme to the IGS of the 
Tetrahymena ribozyme, the reaction yields are drastically decreased.   The yields for rPC-
T are more similar to those seen for rT.  It appears that the P1 and P10 helices from the 
Tetrahymena ribozyme, even though complementary based paired, greatly reduce TES 
product formation with this P. carinii ribozyme (rPC-T).  Note that the decreased product 
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yield, at least in part, is due to additional side reactions occurring between the rPC-T 
ribozyme and the 13mer substrate. 
The kobs values for rPC-T are 0.04 min-1 for the first step and 0.05 min-1 for the 
second step.  Compared to rPC, the first step of the reaction is 125-fold slower and the 
second step is 64-fold slower.  In contrast, the kobs values for the TES reaction with rT 
and rPC-T are quite similar.  Simply by changing the IGS in the P. carinii ribozyme, the 
kobs values for both steps of the TES reaction are greatly decreased.  Presumably, 
changing the P1 and P10 helixes could diminish tertiary interactions at the active site, as 
well as the pre-organization of the substrate.     
 
Optimization of the Hybrid Tetrahymena Ribozyme with the P. carinii IGS and 
Comparison to the P. carinii Ribozyme 
The rT-PC ribozyme is the Tetrahymena ribozyme with the P. carinii IGS (Figure 
4.2.D).  A representative optimization gel and graphs of averaged data are shown in 
Figure 4.6.  The yield-optimized reaction conditions are 100 nM rT-PC and 8 mM MgCl2 
with a reaction time of 40 minutes.  The general trends for each optimized variable for 
rT-PC is similar to what is seen for rT (compare graphs in Figure 4.6 to Figure 4.3).   
The rT-PC TES reaction gives 39.3 ± 2.4% 9mer TES product.  This is 
approximately 60% the amount of maximum product obtained in the rPC TES reaction.  
Compared to the rT ribozyme, the rT-PC ribozyme produces twice as much product.  
Simply by changing the IGS of the Tetrahymena ribozyme to the IGS of the P. carinii 
ribozyme, the reaction yields are dramatically increased.   Surprisingly, the specific P1 
and P10 helices from the P. carinii ribozyme improve TES product yields with the 
Tetrahymena ribozyme.  This is further proof that group I intron-derived ribozymes bind 
and react with complementary sequences differently.  Also, this improved yield for the 
Tetrahymena with the P. carinii substrate may simply reflect that the Tetrahymena 
substrate is inherently problematic. 
The observed rate constants for rT-PC are 0.20 min-1 for the first step and 0.08 
min-1 for the second step.  Compared to rPC, the first step of the reaction is 25-fold 
slower and the second step is 40-fold slower.  This is a mild improvement compared to 
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the observed rate constants for rT.  Another thing to notice about these observed rate 
constants, the kobs for the first step is improved 3-fold compared to the kobs for rT.  
Although this is a small improvement, it is possible that the particular P. carinii substrate 
lends itself to increased rates for the first nucleophilic attack and subsequently more 
efficient 5’-splice site cleavage 
 These results suggest that the identity of the IGS and its fully complementary 
substrate dramatically influence the reaction dynamics of group I intron derived 
ribozymes in general. 
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Discussion 
 
The Tetrahymena Ribozyme Catalyze the TES Reaction 
The TES reaction is a new group I intron-derived ribozyme reaction demonstrated 
with a P. carinii ribozyme (6).  We now show that the L21-Sca I Tetrahymena ribozyme 
catalyzes the TES reaction as well.  The Tetrahymena TES reaction is performed with a 
13mer native Tetrahymena substrate (4.2.C) and produces a 12mer TES product, 
although not as well as the P. carinii ribozyme.   
 
Comparison of the Four Ribozymes 
Among the four ribozymes in this study, the P. carinii ribozyme gives the greatest 
extent of reaction with the highest observed rate constants for both the first and second 
TES reaction steps.  This suggests that there is something inherent with the P. carinii 
ribozyme and its specific P1 and P10 helices that allows for efficient TES.  In 
comparison, the observed rate constants are much lower for the Tetrahymena ribozyme as 
well as the two hybrid ribozymes (compare in Table 4.1).   
The hybrid Tetrahymena ribozyme with the P. carinii IGS (rT-PC) has improved 
yields compared to the Tetrahymena ribozyme (rT), but the rates are not substantially 
improved.  Therefore, simply changing the targeted substrate in the Tetrahymena TES 
reaction can improve the yield of the reaction.  Also, there is no real difference between 
the rates or yields from the Tetrahymena ribozyme (rT) and the hybrid P. carinii 
ribozyme with the Tetrahymena IGS (rPC-T).  Both of these comparisons suggest the 
specific sequence of the Tetrahymena substrate is a major determinant of low yields.   
The TES reaction with the hybrid P. carinii ribozyme (rPC-T) has a 60-fold lower 
observed rate constant compared to the P. carinii ribozyme.  In a previous study, a 10-
fold decrease in the observed rate constant was observed when the P. carinii ribozyme 
was targeted to a different sequence (6).  Clearly, just changing the complementary base 
paired P1 and P10 helices affects the rate of the P. carinii TES reaction.  Work with other 
Tetrahymena reactions has shown that the Tetrahymena ribozyme recognizes the 
structure of the P1 and P10 helices and the specific sequence is not important (27, 67).  
Our results with the P. carinii ribozyme suggest the opposite.  It is likely that introns 
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have evolved in a manner that is somewhat dependent on the sequence of their substrates, 
for example using tertiary interactions that help the ribozyme perform catalysis.     
 
The Tetrahymena Substrate is Problematic in the TES Reaction 
Unfortunately, performing the TES reaction using the native Tetrahymena 
substrate is problematic, as it results in additional and unidentified products, as well as 
lower TES product yields.  It is likely that some of these additional products are formed 
because the P1 helix (formed with the CUCUCU sequence of the 13mer Tetrahymena 
substrate CUCUCUGAAAGGU) docks into the catalytic core out of register, positioning 
the substrate for catalysis at different positions.  Although the Tetrahymena substrate is 
typically cleaved at the –1 position (CUCUCU), it has been shown to cleave at both the –
2 and –3 positions (CUCUUCU and CUCUCU) (69).  This cleavage infidelity has been 
observed in other studies as well (26, 27, 38, 55).  In addition to mispairing, it appears the 
P1 helix could also bind out of register in the catalytic core.  This may explain the 
appearance of smaller products (approximately a 5mer in rT TES reactions and 
approximately a 4mer in rPC-T TES reactions).   
The rPC-T hybrid TES reaction also produces bands approximately seven and 
eight nucleotides in length (Figure 4.5).  These bands were sometimes present in rT TES 
reactions, although they are not prominent in the optimization gel (Figure 4.3).  The 
identity of these products is unknown, but could be due to breakdown of the TES 
product.  In recent work (21), TES products were shown to dissociate from the P. carinii 
ribozyme and lead to smaller breakdown products.  Presumably, the TES product from 
the hybrid rPC-T ribozyme (12mer) could dissociate and rebind another ribozyme, 
leading to these unintended products (7 and 8mer).    
Both the hybrid P. carinii ribozyme (rPC-T) and the native Tetrahymena 
ribozyme (rT) target the native Tetrahymena substrate (Figure 4.2 B and C).  Comparing 
the results of the rPC-T and rT reactions (Figure 4.3 and 4.5), show that the hybrid 
ribozyme has more unintended products than the native ribozyme.  It is suspected that the 
Tetrahymena ribozyme may be able to prevent its native substrate from slipping or the 
product from breaking down by the presence of specific tertiary interactions that have 
evolved to stabilize the native Tetrahymena substrate.  This agrees with what we found 
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for the P. carinii ribozyme, but disagrees with previously published results showing that 
changes to the Tetrahymena ribozyme substrate does not affect catalysis (67).  Additional 
experiments comparing the rT and rPC-T TES reactions need to be conducted to 
conclude that these apparent tertiary interactions are real. 
 
The TES Reaction Depends on Ribozyme Mediated 5’-Site Cleavage 
The ability of a group I intron-derived ribozyme to catalyze the TES reaction 
depends in part on its ability to perform ribozyme-mediated 5’-splice site cleavage.  The 
first step of the TES reaction is cleavage performed by a free hydroxyl from the buffer at 
the ribozyme-mediate 5’-splice site.  Group I intron self-splicing utilizes a 3’-hydroxyl 
from an exogenous G to perform this reaction (see Figure 2.7).  A study comparing the 
rate constants for the chemical step of ribozyme-mediated 5’-splice site cleavage with the 
Tetrahymena ribozyme reacting with the substrate GGCCCUCUAAAAA produced a kc 
of 350 min-1 with saturating G and a kc of 0.7 min-1 in the absence of G (76).  Obviously, 
the Tetrahymena ribozyme does not perform the 5’-splice site cleavage very well without 
G.  Moreover, this rate constant (0.7 min-1) is not substantially different from the 
observed rate constants seen with Tetrahymena in the TES reaction.  It appears that the 
low observed rate constants for the TES reaction with the Tetrahymena ribozyme might 
be linked to inefficient ribozyme-mediated 5’-splice site cleavage.   
   
Implications 
Showing that the Tetrahymena ribozyme can perform the TES reaction indicates 
that the TES reaction is likely a general reaction for group I introns, although the native 
P. carinii ribozyme is much more efficient at the TES reaction than the other three 
ribozyme-substrate combinations tested.  The Tetrahymena TES reaction may work 
better, however, if run with a modified-native substrate.  For example, in other 
Tetrahymena studies, the CUCUCU substrate is often changed to GGCCCUCU, 
apparently to help the substrate bind more tightly and prevent cleavage infidelity (54, 73, 
76).   
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 The ability of the P. carinii ribozyme to perform the TES reaction well appears to 
be due, at least in part, to its ability to perform ribozyme-mediated 5’-splice site cleavage 
efficiently.  The slower rates seen with the Tetrahymena ribozymes, could be related to 
their decreased ability to allow 5’-splice site cleavage.   
Changing the IGS of the P. carinii ribozyme to the Tetrahymena IGS 
substantially decreases the observed rate constants and yield.  Also, the native 
Tetrahymena ribozyme with its native substrate gives fewer unintended product when 
compared to the P. carinii hybrid ribozyme targeting the same substrate.  Apparently, the 
combination of the specific tertiary interactions with the base paired P1 and P10 helices 
have evolved together, and changing the IGS, even to other complementary sequences, 
decreases the rate of reaction.   We show in this study that the specific sequence of the 
IGS does matter.  This has been seen in another P. carinii study ((77) and in Chapter 
Three of this work) and is in contrast to other Tetrahymena studies (27, 67).  
Finally, our results indicate that targeting TES ribozymes to particular sequences 
may be challenging.  Ultimately, it may be difficult to overcome years of evolution that 
has given group I introns the ability to catalysis reactions with specific substrates.  
Nevertheless, the P. carinii ribozyme and the Tetrahymena ribozyme can perform the 
TES reaction in vitro, suggesting that self-spliced group I introns may have the general 
ability to perform the TES reaction even in the cell. 
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 Extent of 
TES Reaction
(%)b
Ribozyme
Concentration
(nM)
Reaction
Time
(min)
MgCl2
Concentration
(mM)
kobs
1st Step
(min)d
rPC 100 15 30a 68.5±4.4%         5.0±1.1 3.2±0.1
rPC-T 100               4             60           25.6±1.3% 0.04±0.01   0.05±0.01
rT 200 10           90          19.1±11.5%c 0.07±0.01 0.05±0.01
rT-PC 100               8            40 39.3±2.4% 0.20±0.01 0.08±0.01
Optimum Conditions Results
kobs
2nd Step
(min)d
aOptimum yields are achieved in as few as 5 minutes. bReactions were optimized to give maximum 
TES product yields.  The yields were calculated with data from at least six independent reactions.  
Errors reported are the standard deviation. cThe extent of reaction for the rT ribozyme is highly 
variable from different batches of ribozyme stock.  Five independent runs from one batch gave 10.9 ±
1.1% 12mer TES product.  Six independent runs from another batch gave 27.2 ± 1.8% 12mer TES 
product.  The value of 19.1 is the average from these two batches and 11.5 is the standard deviation.  
dObserved rate constants were calculated using the average of at least two independent sets of data.  
The 1st step of the TES reaction is calculated as the sum of the percent of 5’cleavage product and TES 
product produced over time.  The 2nd step of the TES reaction is calculated as the percent of TES 
product produced over time.  Errors reported are the standard deviation.
Table 4.1 Tetrahymena, P.carinii, and Hybrid Ribozyme TES Optimum Reaction Condition and Results
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Figure 4.1.  Schematic of the Trans Excision-Splicing Reaction.  The TES substrate has 
three parts; a 5’-exon mimic shown in pink, the insert region shown in green, and a 3’-
exon mimic shown in light blue.  The green segment in the TES substrate will be 
removed and requires a guanosine (G) as the last or only nucleotide (if cutting out just 
one nucleotide) in its sequence.  The ribozyme is dark blue.  1) The ribozyme recognizes 
the TES substrate in part through base pairing, forming a P1 and P10 helix.  2) The first 
nucleophilic attack is performed by an exogenous hydroxyl group, presumably from the 
buffer.  This first attack occurs at the splice site formed at the end of the P1 helix.  After 
the first nucleophilic attack, the 5’-exon mimic (shown in pink) is no longer attached to 
the rest of the substrate and has a free 3’-hydroxyl (OH) group.  3) The free 3’-OH on the 
5’-exon mimic performs the second nucleophilic attack at the phosphate linking the final 
guanosine in the insert and the 3’-exon mimic (the junction between the green and light 
blue segments in the TES substrate).  The second attack results in removal of insert 
sequence (green) and the ligation of the 5’ and 3’-exon mimics (pink and light blue). 
 72 
rT-PCrTrPC rPC-TA
5’ 3’C
U
C
U
C
A
G
U
A
G
A
G
G
G
U
C
A
U
G
3’
rPC
9mer 
TES Product
5’
P1
P10
B
5’
U
G
G
A
A
A
U
C
U
C
U
C
G
G
A
C
C
U
U
U
G
G
A
G
G
G
rPC
3’
12mer 
TES Product
5’
3’
P1
P10
C
3’
5’
U
G
G
A
A
A
U
C
U
C
U
C
G
G
A
C
C
U
U
U
G
G
A
G
G
G
rT
12mer 
TES Product
5’
3’
P1
P10
D
5’ 3’C
U
C
U
C
A
G
U
A
G
G
A
G
G
G
U
C
A
U
3’
rT
9mer 
TES Product
5’
P1
P10
 
 
Figure 4.2.  Diagrams of the Tetrahymena, P. carinii, and hybrid ribozymes base paired 
to their complementary TES substrate.  The ribozymes are shown in black and only the 
IGS is detailed.  The 10mer and 13mer substrates are shown in pink (5’-exon mimic), 
green (nucleotide to be removed), and light blue (3’-exon mimic). A) The P. carinii 
ribozyme (rPC) and the 10mer substrate produce a 9mer TES product. B) The hybrid P. 
carinii ribozyme with the Tetrahymena IGS (rPC-T) and the 13mer substrate produce a 
12mer TES product. C) The original Tetrahymena ribozyme (rT) and its 13mer substrate 
produce a 12mer TES product.  D) The hybrid Tetrahymena ribozyme with the P. carinii 
IGS (rT-PC) and the 10mer substrate produce a 9mer TES product.  
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Figure 4.3.  Representative polyacrylamide gel and graphs of rT TES optimization.  The 
TES reaction yields were optimized for ribozyme concentration, MgCl2 concentration, 
and time.   Reactions were run in buffer consisting of 50 mM HEPES (25 mM Na+) and 
135 mM KCl and under optimum conditions of 200 nM rT and 10 mM MgCl2 for 90 min, 
except for the changing variable.  The gel shows 13mer starting material, 6mer 5’-splice 
site cleavage intermediate, and 12mer TES product.  The size control was 13mer 
(CUCUCUGAAAGGU) and 6mer (AUGACU).  Note that the AUGACU 6mer runs 
slightly higher than the CUCUCU 6mer.  The graphs show the percent 12mer (TES 
product) with filled circles and percent 6mer (5’cleavage product) with opened circles.  
The graphs represent the average of two independent reactions.  Standard deviations were 
typically below ten percent for each point. 
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Figure 4.4.  Representative polyacrylamide gel and graphs of rPC TES optimization.  The 
TES reaction yields were optimized for ribozyme concentration, MgCl2 concentration, 
and time.  Reactions were run in buffer consisting of 50 mM HEPES (25 mM Na+) and 
135 mM KCl and under optimum conditions of 100 nM rPC and 15 mM MgCl2 for 30 
min, except for the changing variable.  The gel shows 10mer starting material, 6mer 5’-
splice site cleavage intermediate, and 9mer TES product.  The size control was 10mer 
(AUGACUGCUC) and 6mer (AUGACU).  The graphs show the percent 9mer (TES 
product) with filled circles and percent 6mer (5’cleavage product) with opened circles.  
The graphs represent the average of three independent reactions.  The standard deviations 
were typically below ten percent for each point. 
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Figure 4.5.  Representative polyacrylamide gel and graphs of rPC-T TES optimization.  
The TES reaction yields were optimized for ribozyme concentration, MgCl2 
concentration, and time.  Reactions were run in buffer consisting of 50 mM HEPES (25 
mM Na+) and 135 mM KCl and under optimum conditions of 100 nM rPC-T and 4 mM 
MgCl2 for 60 min, except for the changing variable.  The gel shows 13mer starting 
material, 6mer 5’-splice site cleavage intermediate, and 12mer TES product.  The size 
control was 13mer (CUCUCUGAAAGGU) and 6mer (AUGACU).  Note that the 
AUGACU 6mer runs slightly higher than the CUCUCU 6mer.  The graphs show the 
percent 12mer (TES product) with filled circles and percent 6mer (5’cleavage product) 
with opened circles.  The graphs represent the average of at least three independent 
reactions.  Standard deviations were typically below fifteen percent for each point. 
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Figure 4.6  Representative polyacrylamide gel and graphs of rT-PC TES optimization.  
The TES reaction yields were optimized for ribozyme concentration, MgCl2 
concentration, and time.  Reactions were run in buffer consisting of 50 mM HEPES (25 
mM Na+) and 135 mM KCl and under optimum conditions of 100 nM rT-PC and 8 mM 
MgCl2 for 40 min, except for the changing variable.  The gel shows 10mer starting 
material, 6mer 5’-splice site cleavage intermediate, and 9mer TES product.  The size 
control was 10mer (AUGACUGCUC) and 6mer (AUGACU).  The graphs show the 
percent 9mer (TES product) with filled circles and percent 6mer (5’cleavage product) 
with opened circles.  The graphs represent the average of four independent reactions.  
Standard deviations were typically below fifteen percent for each point. 
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CHAPTER FIVE - Trans Insertion-Splicing: A Novel Group I Intron-Derived 
Ribozyme Mechanism for Inserting One RNA Sequence into Another 
 
Introduction 
 
We recently reported a trans excision-splicing (TES) reaction, developed with a 
P. carinii group I intron-derived ribozyme, which can bind an exogenous RNA substrate, 
remove a section from the middle, and splice the ends back together (Figure 5.1.A) (6, 
20, 21).  We now report a new group I intron-derived ribozyme reaction called trans 
insertion-splicing (TIS) where one RNA substrate is directly inserted into a second RNA 
substrate.  A simple schematic is shown in Figure 5.1.B.  The ability of a group I intron-
derived ribozyme to perform the TIS reaction was confirmed by enzymatic sequencing of 
the product.  Reactions were optimized for both yield and rate, with optimum reactions 
ultimately run in 10 mM MgCl2 for two hours.  Reaction products are stable, with no 
visible loss at extended times.  A three-step mechanism was elucidated using modified 
substrates to trap isolated reaction steps.  Although the same P. carinii ribozyme is used 
in the TES reaction, the TIS reaction is not the reverse of the TES reaction.  In fact, 
attempts to directly reverse TES were unsuccessful, due to an inability to reverse the 5’-
splice site cleavage reaction that occurs as the first step of TES.   
The TIS reaction is the first example of the direct insertion of one exogenous 
RNA into a second exogenous RNA using a ribozyme essentially unaltered from its 
intronic form.  Apparently, such introns are capable of more dynamic reactions than 
previously shown.  The proposed mechanism for the TIS reaction and implications for 
group I intron-derived ribozyme reactions are discussed. 
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Materials and Methods 
 
Synthesis and Preparation of Oligonucleotides 
RNA oligonucleotides were purchased from Dharmacon Research, Inc. 
(Lafayette, CO) and deprotected according to the manufacture’s instructions.  
Oligonucleotide concentrations were calculated based on UV-absorption measurements 
using a Beckman DU 650 UV-Spectrophotometer (Beckman Coulter, Inc., Fullerton, 
CA).  Designated oligonucleotides were 5’-end radiolabeled and purified by gel 
electrophoresis as described previously (17).  Designated oligonucleotides were 3’-end 
radiolabeled by ligating 5’-end radiolabeled Cp to the 3’-end of the oligonucleotide.  The 
Cp was 5’-end radiolabeled in 10 μL consisting of 5 μL of 250 μCi 32P-δATP 
(Amersham-Pharmacia, Piscataway, NJ), 2 μL of 50 mM cytidine 5’ monophosphate 
(CMP) (Sigma, St. Louis, MO), 1 μL of 10U/μL T4 poly-nucleotide kinase (New 
England Biolabs, Beverly, MA), and 1 μL of 10X poly-nucleotide kinase buffer (supplied 
by New England Biolabs).  The reaction was run for 90 min at 37oC, and then the kinase 
was deactivated by incubation at 65oC for 15 min.   5’-end radiolabeled pCp (5’-*pCp) 
was ligated to the 3’-end of the oligonucleotide in a 10 μL reaction mixture consisting of 
1 μL of DMSO, 2 μL of 10 μM RNA, 2 μL of 20U/μL T4 RNA ligase (New England 
Biolabs), 4 μL of 5’-*pCp (approximately 20 μM), and 1 μL of 10X T4 RNA ligase 
buffer (New England Biolabs).  The reactions were incubated for 16 h at 4oC.  The 3’-
radiolabeled oligonucleotides were purified by gel electrophoresis as described for the 5’-
end radiolabeled oligonucleotides.  The substrate names and sequences are shown in 
Table 5.1. 
 
Ribozyme Preparation 
The PC ribozyme plasmid (proposed secondary structure of the rPC ribozyme 
shown in Figure 5.2) was linearized in a 50 μL reaction mixture consisting of 8 μg of 
plasmid, 50 U of XbaI (Invitrogen, Grand Island, NY), and 1x React 2 buffer at 37oC for 
2 h.  Linearization was confirmed by visualization on a 1% agarose gel.  The linearized 
DNA was purified using a QIAquick PCR Purification Kit (Qiagen Inc., Valencia, CA) 
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and eluted in water.  Five other ribozymes with varying 3’-ends were made from the PCR 
products derived from the PC plasmid (Table 5.1).  The upstream PCR primer for all five 
ribozymes was 5’CTCTAATACGACTCACTATAGAGGG3’.  The following sequences 
are the downstream primers for each ribozyme (the variable region is underlined): 
5’CACAATATACTCTTTCTTTCGAAAGAGG3’ for rPC-1, 
5’TTAGATATACTCTTTCTTTCGAAAGAGG3’ for rPC-ωA, 
5’CACGAGCTAGATATACTCTTTCTTTCGAAAGAGG3’ for rPC-3, 
5’CACGAGTTAGATATACTCTTTCTTTCGAAAGAGG3’ for rPC-3-ωA, and 
5’ATGTTTCACGAGCTAGATATACTCTTTCTTTCGAAAGAGG3’ for rPC-4.  The 
PCR products were gel purified using a Qiagen gel extraction kit (Qiagen Inc.).  Run-off 
transcription was performed for 2 h in 100 μL reactions consisting of 1-2 μg of linear 
DNA, 50 U of T7 RNA polymerase (New England Biolabs), 40 mM Tris-HCl (pH 7.5), 
10 mM MgCl2, 5 mM DTT, 5 mM spermidine, 1 mM rNTP mix, and 62.5 μg/mL BSA.  
The ribozymes were purified using a Qiagen RNeasy purification kit (Qiagen Inc.).    
 
The Trans Insertion-Splicing Reaction  
The extent of the TIS reaction was optimized over a range of rPC concentration 
(10 to 1000 nM), 9mer insert concentration (10 to 3000 nM), MgCl2 concentration (2 to 
50 mM), time (1 to 180 min), and temperature (37o to 50oC) for the reaction with 5’-end 
radiolabeled 12mer starting material AUGACUAAACAU.  Ultimately, optimum 
reactions were found to consist of 2 h at 44oC with 200 nM rPC, 1 μM 9mer insert, and 
10 mM MgCl2.  All reactions were run using approximately 1 nM 5’-end radiolabeled 
12mer starting material in a buffer consisting of 50 mM Hepes (25 nM Na+) and 135 mM 
KCl at pH 7.5.   
In the reactions, first 3 μL of ribozyme in appropriate buffer was pre-annealed at 
60oC for 5 min.  The ribozyme was then slowly cooled to 44oC.  Reactions were initiated 
by adding 2 μL of pre-combined substrates (radiolabeled starting material and cold 
insert).  Reactions were terminated after 2 h by adding 5 μL stop buffer (10 M urea, 3 
mM EDTA, 0.1x TBE).  The reactions were denatured for 1 min at 90oC and then 
separated on a 12% polyacrylamide/8M urea gel.  The gel was transferred to 
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chromatography paper and dried under vacuum.  The bands were visualized and 
quantified on a Molecular Dynamics Storm 860 Phosphorimager.  The observed rate 
constant, kobs, for the TIS reaction was obtained from the plot of percent TIS product 
formed over time (17).  
 
Product Isolation and Identification 
The TIS product was gel purified and sequenced by partial nuclease digestion 
along with the synthetic version of the expected product.  The TIS reaction was scaled up 
50-fold (250 μL) and run as described above using the optimized conditions, except the 
reactions were run in five 50 μL volumes, concentrated to 30 μL after 2 h, and terminated 
with 10 μL stop buffer.  The product band was ultimately cut out of the gel and eluted 
from the gel matrix for 40 min by crushing with a stir bar in 400 μL of elution buffer (0.3 
M sodium acetate, 5 mM EDTA, 10 mM Tris-HCl pH 7.5, and 0.1% SDS).  The eluent 
was decanted and a second round of elution was performed.  The product was ethanol 
precipitated overnight and concentrated to 30 μL.  The radiolabeled TIS product and 
synthetic 18-mer were enzymatically sequenced using RNA nucleases T1, U2, CL-3 and, 
B. cereus (Research Unlimited; Wellington, New Zealand) essentially as described (6).  
B. cereus reactions used 0.33 units B. cereus in 33 mM sodium citrate (pH 5.0) and 1.7 
mM EDTA. 
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Results 
 
The P. carinii Group I Intron Catalyzes the TIS Reaction. 
Work on the TIS reaction began by simply trying to reverse the TES reaction 
(Figure 5.1.A).  Instead of just one substrate, the TIS reaction begins with two substrates 
(referred to as starting material and insert in Figure 5.1.B).  TIS experiments initially 
attempted (data not shown) with a P. carinii ribozyme and TES products resulted only in 
recombination (the 3’-half of one substrate exchanged for the 3’-half of the other 
substrate).  This recombination reaction appeared to be the first step of the TIS reaction, 
so the substrates were redesigned to help achieve the expected second step.  Reactions 
with these new substrates and the ribozyme rPC (secondary structure in Figure 5.2) gave 
a larger product (potential insertion), but it was not the size we expected.  To ensure that 
we were producing an insertion product, we tested whether this large product contained 
both the 5’ and 3’-terminal regions from the starting material.  We did this by running the 
reaction with 5’ and 3’-end radiolabeled starting material, since the insertion product 
should contain both the 5’-end (Figure 5.1.B, in pink) and the 3’-end (Figure 5.1.B, in 
light blue).  We appear to form the same product with both 5’-end radiolabeled starting 
material (Figure 5.3, lane A) and 3’-end radiolabeled starting material (Figure 5.3, lane 
B).  Note that the 3’-end radiolabeled reaction product is one nucleotide larger due to the 
method of radiolabeling.  For confirmation, the product band was excised from the 
polyacrylamide gel and its sequence was confirmed by enzymatic sequencing (Figure 
5.4).  The 18mer product AUGACUUCUCGUGAAACAU appears to be the result of the 
insertion of the underlined region of the 9mer insert, GCUCUCGUG, into the middle of 
the 12mer starting material, AUGACUAAACAU.  Although the exact TIS product was 
unexpected, this was the first evidence that group I intron-derived ribozymes can catalyze 
the TIS reaction. 
The reaction was optimized in terms of the yield (Figure 5.5) and the observed 
rate constant (Figure 5.6).  Optimum reaction conditions for TIS are 200 nM ribozyme 
(rPC), 1 μM 9mer insert, and 10 mM MgCl2 using 1 nM 12mer radiolabeled starting 
material (see Figure 5.5).  The TIS reaction produces 62.9 ± 1.3% 18mer TIS product and 
the reaction is complete at two hours.  Times studies were performed at four different 
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MgCl2 concentrations and the observed rate constants, kobs, were determined (Figure 5.6).  
The kobs value for the TIS reaction is 0.04 min-1, and is the same at 10, 14, and 18 mM 
MgCl2.  The kobs value when using 6 mM MgCl2, however, was 0.02 min-1, which is half 
the kobs for the optimum condition and results also in half the yield.  Apparently MgCl2 
concentrations as low as 6 mM inhibit the ability of the ribozyme to fold, as well as to 
catalyze the reaction.    
The mechanism of the TIS reaction was elucidated by analyzing the effects of 
modifying functional groups in the substrates and ribozyme, and by initiating the reaction 
using intermediates as starting material.  Key to the elucidation of the mechanism was the 
discovery that a large intermediate product, indicative of the substrate attached to the 
ribozyme, was observed only when substrates were 3’-end radiolabeled (and not when 
they were 5’-end radiolabeled).  This suggested that the ωG on the ribozyme was 
involved in catalysis and that intermediates were attached to the ribozyme.  The proposed 
TIS mechanism is shown in Figure 5.7.     
  
Step 1: The ωG on the Ribozyme Performs a Nucleophilic Attack on the Insert. 
The sequencing results show that the 9mer insert is losing its 5’-GCU 
(GCUCUCGUG) during the TIS reaction (depicted in Figure 5.1.B).  The loss of this 
GCU 3mer from the insert suggests that the insert might first be forming a P1 helix 
(called P1i) with the IGS of the ribozyme (Figure 5.7, 2a).  This interaction would place a 
G-U wobble pair at the 5’-splice site where the ωG on the ribozyme could attack the 
insert.   
To show that the ribozyme’s ωG is involved in the mechanism proposed in Figure 
5.7, the ωG in rPC was replaced with an ωA (rPC-ωA).  Although an ωA has been shown 
to give the second step of splicing in a group I intron from Anabaena (82), an adenosine 
was used to test the TIS reaction because the GBS in the P. carinii ribozyme has been 
shown to not functionally interact with adenosine for the second step of the TES reaction 
(21).  We expect that if the ωG in the ribozyme is important, its alteration would prevent 
the first reaction, as well as TIS product formation.  In this reaction, using 5’ or 3’-end 
radiolabled 12mer starting material, no appreciable 18mer TIS product formed (Figure 
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5.3, lanes C and D).  Note that in the 5’-end radiolabeled reaction (Figure 5.3, lane C), 
production of 6mer is occurring through ribozyme mediated hydrolysis at the 5’-splice 
site as seen in the TES reaction with the same ribozyme (6).  Also, in the 3’-end 
radiolabeled reaction (Figure 5.3, lane D), much less of the large intermediate band forms 
compared to the reaction using rPC (compare to Figure 5.3, lane B), as expected if the 
ribozyme cannot perform the first step of the TIS reaction.  Note that transcription using 
T7 RNA polymerase has been shown to add extra nucleotides to the 3’-end of transcripts 
and that a faint 18mer or intermediate band might be due to the addition of Gs to the 3’-
end of the ribozyme in that process.   
To test that the 9mer insert is forming a P1i helix (as depicted in Figure 5.7, 2a), 
the 9mer insert was shortened on either the 5’ or 3’-end.  The 7mer-minus-3’UG insert 
(GCUCUCG _ _) is shortened by two nucleotides on its 3’-end.  This insert can still form 
a P1i helix, but should give a shortened TIS product.  Reactions run with 5’-end 
radiolabeled 12mer starting material, rPC ribozyme, and 7mer-minus-3’UG insert (Figure 
5.3, lane G) show production of a shorter TIS product, as expected.  Likewise, the insert 
was shortened by two nucleotides on its 5’end, 7mer-minus-5’GC insert (_ _ 
UCUCGUG), which should disrupt P1i formation.  Reactions run with 5’-end 
radiolabeled 12mer starting material, rPC ribozyme, and 7mer-minus-5’GC insert (Figure 
5.3, lane F) show no TIS production and indicate that the insert is forming a P1i helix in 
the TIS reaction.   
Since the 9mer insert loses its 5’GCU and appears to form a P1i helix, an insert 
with a deoxy-U at the critical position forming the 5’-splice site (9mer-dU, 
GCdUCUCGUG) was tested to see if this change inhibits 18mer production.  If catalysis 
is occurring at this position in the 9mer, the substitution of a deoxy-U should either 
prevent or greatly inhibit TIS.  The reaction run with 5’-end radiolabeled 12mer starting 
material, rPC ribozyme, and 9mer-dU insert gives greatly inhibited TIS production 
(Figure 5.3, lane H), as expected.   
To directly show that the ribozyme is attacking the 9mer insert, reactions were run 
with 5’-end radiolabeled insert instead of radiolabeled starting material.  These reactions 
are run with much less insert compared to the standard reaction, and therefore, are not 
under optimum conditions.  Nevertheless, when the reaction is run with 5’-end 
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radiolabeled 9mer insert (GCUCUCGUG), all of the 9mer is cleaved to a smaller product 
(Figure 5.3, lane J), which appears to be the expected 3mer side product GCU.  Running 
the reaction using the ribozyme rPC-ωA and 5’-end radiolabeled 9mer gives some of the 
3mer product, but cleavage at this position is greatly inhibited (Figure 5.3, lane K), as 
expected without an ωG on the ribozyme.  The 3mer produced in this reaction is 
presumed to be through ribozyme-mediated cleavage since the ωA in the ribozyme 
cannot attack at the splice site.   
When the reaction is run with 3’-end radiolabeled 9mer insert (also not run with 
optimum TIS insert concentrations), a large intermediate band forms (Figure 5.3, lane 
M).  This expected band is intermediate formed by the insert attaching to the 3’-end of 
the ribozyme (shown in Figure 5.7, 3a).  The formation of this large intermediate band is 
greatly inhibited when 3’-end radiolabeled 9mer is run with rPC-ωA (Figure 5.3, lane O).  
Likewise, this inhibition also occurs when running the reaction with 3’-end radiolabeled 
9mer-dU (Figure 5.3, lane N).   These results indicate that the 9mer loses the 3mer 
(5’GCU) from its 5’-end and the 3’-portion of the insert becomes ligated to the 3’-end of 
the ribozyme in the process (Figure 5.7).   
Taken together, these results suggest that the 9mer insert binds the IGS of the 
ribozyme, forming a P1i helix.  The P1i helix positions the G-U wobble pair at the 5’-
splice site, and the ωG on the ribozyme performs the first nucleophilic attack at this 
position.   
 
Step 2: The ωGi on the Insert Performs a Nucleophilic Attack on the Starting Material. 
Once the insert fragment is attached to the 3’-end of the ribozyme, the 12mer 
starting material binds the ribozyme and forms a P1 helix.  This second P1 helix 
formation presumably requires a conformational shift.  The 3’-G on the insert now acts 
like the ωG of the ribozyme (called ωGi) and can attack the G-U wobble pair at the new 
5’-splice site in the starting material (Figure 5.7, 3a).   
The importance of the ωGi on the 9mer insert was tested by changing the ωGi to 
an ωAi (GCUCUCGUA, called 9mer-ωAi).  In the second step of TIS, if the ωGi on the 
insert (once its attached to the ribozyme) is acting as the ωG of the ribozyme, then 
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changing this position to an ωA should prevent the TIS reaction.  Running the TIS 
reaction with 5’-end radiolabeled 12mer starting material, rPC ribozyme, and 9mer-ωA 
gives no 18mer TIS product (Figure 5.8, lane C).  For comparison, the standard TIS 
reaction is shown in Figure 5.8, with the 5’-end radiolabeled reaction in lane A and the 
3’-end radiolabeled reaction in lane B.  The reaction run with 3’-end radiolabeled 12mer 
starting material, rPC ribozyme and 9mer-ωA insert also shows no TIS product (Figure 
5.8, lane D).  Evidently, the ωGi on the insert is critical to the TIS reaction.  Since the 
rPC ribozyme has an ωG, the 6mer (Figure 5.8, lane C) and the large intermediate 
(Figure 5.8, lane D) are likely due to the competing reaction depicted in Figure 5.7, 2b.  
The TIS reaction was initiated at the second step of the three-step reaction by 
reacting 12mer starting material with an intermediate ribozyme (rPC-3) that has the insert 
fragment already attached to its 3’-end (Figure 5.7, frame 3a).  This TIS reaction was run 
exactly like the standard TIS reaction, except no 9mer insert was added.  As seen in 
Figure 5.8, lane F, the reaction of the rPC-3 ribozyme and 5’-end radiolabeled 12mer 
starting material produces 18mer TIS product.  Since no insert is added to the reaction, 
the inserted sequence must be coming from the 3’-end of the ribozyme.  The lower 
product yields are not surprising, probably because the insert sequence on the ribozyme 
intermediate (rPC-3) may not be positioned properly for the second nucleophilic attack 
without undergoing the first reaction step.   
The second step of the TIS reaction depends on a nucleophilic attack at the 5’-
splice site in the P1 helix formed by the 12mer starting material.  This was tested by 
changing the ribo-U at the 5’-splice site to a deoxy-U (12mer-dU, 
AUGACdUAAACAU).  In the reaction with 5’-end radiolabeled 12mer-dU starting 
material, the ribozyme intermediate rPC-3, and no 9mer insert added), no TIS product 
forms (Figure 5.8, lane J) and very little 5’-cleavage (6mer production) occurs.  Likewise, 
the same reaction run with 3’-end radiolabeled 12mer-dU shows no TIS product (Figure 
5.8, lane K).  Clearly, changing the ribo-U to a deoxy-U at this position in the 12mer 
starting material (AUGACdUAAACAU) suggests that this position forms the second 5’-
splice site.  
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These results show that the second step of the TIS reaction depends on the 12mer 
starting material forming a P1 helix with the ribozyme, as well as the ωGi on the insert 
acting as the nucleophile in the 5’-cleavage reaction. 
 
Step 3: The 3’-U on the 5’-half of the Starting Material Attacks the ωG of the Ribozyme, 
Forming TIS Product. 
After the second step of the TIS reaction, the 3’-half of the starting material as 
well as the insert region, is attached to the 3’-end of the ribozyme (Figure 5.7, 4a).  The 
3’-U on the 5’-half of the starting material can then mimic the second step of self-splicing 
and attack at the ωG (and not at ωGi) of the ribozyme.  To initiate the reaction at the third 
reaction step, we synthesized the ribozyme intermediate rPC-4, which has the insert and 
3’-half of the starting material on the 3’-end of the ribozyme (Figure 5.7, 4a).  The 
reaction was run with 5’-end radiolabeled 6mer (AUGACU, the 5’-half of the 12mer 
starting material) and rPC-4 ribozyme intermediate.  This reaction produces the expected 
18mer TIS product (Figure 5.8, lane M).  Since the 18mer product forms with only 6mer 
added, the product sequence must be coming from the ribozyme, as proposed (Figure 5.7, 
4a).  The control reaction of 5’-end radiolabeled 6mer and rPC (the standard ribozyme) 
(Figure 5.8, lane O), shows no 18mer product.  In addition, running the reaction with 
rPC-4 and the 6mer with its 3’-ribo-U changed to a deoxy-U (AUGACdU called 6mer-
dU) greatly reduces TIS product (Figure 5.8, lane N), indicating that the 3’-U on the 5’-
half of the starting material is the nucleophile for the third reaction step.      
Finally, the third step of the reaction can be inhibited by changing the ωG in the 
rPC-3 intermediate ribozyme to an ωA (rPC-3ωA in Table 1).  The reaction utilizing 
12mer starting material and rPC-3ωA initiates at the second step of TIS (Figure 5.7, 3a), 
but the ωA should inhibit the TIS reaction at the third step (Figure 5.7, 4a).  The results 
show less 18mer product forms (Figure 5.8, lane G), as expected, compared to the 
reaction with rPC-3 (Figure 5.8, lane F).  This result suggests that the ωG in the ribozyme 
is not only required for the first step but is important for the third step of the TIS reaction 
as well.   
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From these results, it appears that the 3’-U on the 5’-half of the starting material 
attacks at the ωG in the ribozyme to form the TIS product. 
 
P9.0 Formation Inhibits the TIS Reaction 
The TIS reaction was also run with the native P. carinii intron sequence (called 
rPC-1). In reactions with rPC-1, 18mer product yields were 6-fold lower than with rPC 
(11.0±0.8% compared to 62.9±1.3%).  The only difference between the rPC-1 and rPC 
ribozymes is three nucleotides at the 3’-end of the ribozymes (Figure 5.9).  This 
difference allows only rPC-1 to form a P9.0 helix.  Apparently P9.0 formation inhibits 
the TIS reaction, perhaps because it inhibits the proposed conformational shift that occurs 
between the first and second steps, essentially halting the reaction at the second step.   
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Discussion 
 
The P. carinii Group I Intron-Derived Ribozyme Catalyzes the TIS Reaction 
 We report that a P. carinii ribozyme can insert one RNA substrate into another 
(the trans insertion-splicing reaction), in a yield of up to 63%, which is surprisingly high 
for a three-step mechanism.   
 
The TIS Mechanism 
All evidence suggests there are three reaction steps in forming the 18mer TIS 
product (Figure 5.7).  Step 1: The 9mer binds the IGS of the ribozyme forming a P1i 
helix, and the ωG on the ribozyme then attacks at the 5’-splice site, giving GCU + rPC-
ωGCUCGUG + AUGACUAAACAU (Figure 5.7, 2a).  This reaction step appears to be 
the same as the reverse of the second step of group I intron self-splicing (70), and has 
been seen in other ribozyme reactions (16, 83-85).  Step 2: The 12mer starting material 
displaces the insert fragment and forms a second P1 helix.  The ωGi from the 9mer insert 
(attached to the 3’-end of the ribozyme) attacks at the G-U wobble pair at the second 5’-
splice site, giving AUGACU + rPC-ωGCUCGUGAAACAU (Figure 5.7, 3a).  This step 
is similar to the first reaction step (described above).  Step 3: The free 3’-OH on the 3’-U 
of AUGACU can then attack at the ωG of the ribozyme intermediate (rPC-
ωGCUCGUGAAACAU), releasing the 18mer TIS product 
AUGACUCUCGUGAAACAU (Figure 5.7, 4a).  This reaction step appears to be the 
same as the second step of group I intron self-splicing (70).  A competing reaction occurs 
when the 12mer starting material forms the P1 helix first (before the insert forms the P1i 
helix).  This reaction results in the formation of 6mer (AUGACU) and the 3’-end of the 
12mer (AAACAU) attached to the 3’-end of the ribozyme (Figure 5.7, 2b).  This 
ribozyme intermediate has no ωG and therefore cannot perform the TIS reaction.   
The TIS reaction, along with other ribozyme reactions (16, 83-85), is dependent 
on the ribozyme ending in G (which is called ωG).  There is evidence that the T7 RNA 
polymerase used to synthesize RNA frequently adds one or two template-independent 
nucleotides onto the 3’-end of RNA transcripts (86).  There is no simple way to ensure 
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that extra nucleotides are not being adding to our ribozymes.  Nevertheless, when we 
synthesize the ribozymes ending in ωA, it substantially prevents reactivity (Figure 5.3, 
lane C).  Although template-independent nucleotides may be added to the TIS ribozymes, 
it appears they are not predominantly Gs.  This agrees with other studies that show the 
extra nucleotides added by T7 RNA polymerase tend to be mostly As and Cs (86, 87).    
 
Factors that Influence the TIS Reaction 
 The TIS reaction was optimized for both yield and rate.  The optimum reaction 
conditions are 10 mM MgCl2, 200 nM rPC ribozyme, and 1 μM 9mer insert, using 1nM 
radiolabeled starting material (Figure 5.5).  These optimum reaction conditions give a 
200:1000:1 ratio of ribozyme, insert, and starting material.  The relative proportions of 
these reaction components are fairly specific, as decreasing or increasing the 
concentrations of insert or ribozyme gives decreased TIS product yields.  At ribozyme 
concentrations higher than 200 nM, the amount of 18mer product decreases (Figure 5.5). 
This decrease could be due to the insert and starting material not binding the same 
ribozyme.  The product yield might increase if the insert concentration was likewise 
increased.  Another possibility is that higher concentrations of ribozyme may lead to TIS 
product breakdown, although our time studies do not support this possibility. 
TIS reactions run with insert concentrations higher than the optimum (1 μM) also 
show a decrease in 18mer product formation.  This could be due to the 12mer starting 
material not competing as well for binding the IGS in the presence of increased 9mer 
insert concentration.   
The optimum MgCl2 range is fairly narrow, with 10-14 mM MgCl2 being 
optimum (Figure 5.5).  Decreased TIS product at higher MgCl2 concentrations is most 
likely due to the increased strength of binding of the substrates to the ribozyme, since 
Mg2+ ions allow for tighter binding.  Therefore, the delicate balance between formation 
of the P1i and the P1 helices is likely disrupted at higher MgCl2 concentrations.    
 The reactions were optimized for rates (Figure 5.6) by performing time studies at 
different MgCl2 concentrations.  The optimum reaction time for TIS is two hours and no 
degradation of the TIS product is seen at extended reaction times.  This indicates that the 
TIS product is stable once it forms.  Obtaining the same observed rate constant at 10, 14, 
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and 18 mM MgCl2 concentrations indicates that the TIS reaction is optimized for rate.  
The yield and the observed rate constant were half the optimum values when the TIS 
reaction was run at 6 mM MgCl2.  This indicates that reactions run with less than the 
optimum MgCl2 concentration may not allow the intron to fold properly, leading to 
decreased yields and rates.  Obtaining an optimum rate but a decreased yield at 18 mM 
MgCl2 suggests that too high MgCl2 concentrations affect primarily the folding and not 
the chemistry of the reaction. 
 We can compare the observed rate constants for the TIS and TES reactions.  The 
observed rate constant for the TIS reaction (0.04 min-1) is 80-fold lower than for the TES 
reaction (3.2 min-1).  This is not surprising since the TIS reaction binds two exogenous 
substrates in succession and proceeds through three catalytic steps.  In comparison, the 
TES reaction binds one exogenous substrate and proceeds through two catalytic steps.  In 
addition, large conformational changes are likely necessary for the TIS reaction that are 
not necessary for the TES reaction. 
Also, it appears that P9.0 formation inhibits the TIS reaction.  The TIS reaction 
mechanism requires a conformational shift between the first and second nucleophilic 
attacks to disrupt the P1i helix and form the P1 helix.  In group I introns, the P9.0 helix 
forms with the two nucleotides preceding ωG of the intron and can help position the ωG 
into the GBS (35-37).  In addition, the GBS in the ribozyme binds both the exogenous G 
and ωG for the first and second nucleophilic attacks, respectively.  Sullenger has shown 
that a Tetrahymena group I intron-derived ribozyme has different affinities for binding 
either the exogenous G or the ωG in the GBS between the two steps of trans-splicing 
(80).  We suspect that a similar change in affinity for binding ωG and ωGi in the GBS is 
important for the TIS reaction.  In our proposed mechanism, ωG on the ribozyme 
interacts with the GBS in the first step of the TIS reaction, although no P9.0 forms with 
the rPC ribozyme (Figure 5.9).  After the first step of the TIS reaction, the insert is 
attached to the ribozyme and the formation of a P9.0 helix at this point could help 
position the ωGi of the insert in the GBS for the second step of the TIS reaction (see 
Figure 5.7, 3a).  If the ribozyme forms a P9.0 in the first reaction step, this could inhibit 
the second step of the TIS reaction by preventing the ωGi from interacting with the GBS.  
The 6-fold decrease in product yields for the TIS reaction with the rPC-1 ribozyme 
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(compared to the rPC ribozyme with no P9.0) suggests that P9.0 formation in the 
ribozyme does indeed inhibit the TIS reaction.    
 
Comparison with Previous Studies 
The TIS reaction involving the direct insertion of one RNA substrate into another 
RNA by a group I intron-derived ribozyme has not been previously reported.  The TIS 
reaction is the reverse of the TES reaction, where a segment is removed from the middle 
of an RNA substrate (6), although it is not the reverse in terms of the mechanism.  
Another ribozyme reaction performed with an engineered twin hairpin ribozyme results 
in replacement of one RNA sequence with a longer sequence, which is essentially an 
“insertion” product (88).  The TIS reaction differs from this twin ribozyme reaction by 
the type of ribozyme used and also the reaction mechanism.  The twin ribozyme reaction 
is much less efficient, taking 30 hours and producing 30% product compared to the TIS 
reaction that is complete in 2 hours with product yields around 60%.     
Other ribozyme reactions involve the insertion of large intronic sequences into 
RNA transcripts.  The reverse-splicing reaction is when a group I intron splices back into 
an RNA transcript (89).  Group II introns can act as mobile genetic elements by splicing 
out of an RNA transcript, and then reverse-splicing into DNA (reviewed in (90)). These 
reactions differ from the TIS reaction because the inserted fragment is an exogenous 
substrate in TIS, not the intron itself. 
Other group I intron-derived ribozyme reactions have taken advantage of ωG.  A 
Tetrahymena intron was found to act as an enzyme by using its ωG to cleave and rejoin 
pentacytidylic acid, synthesizing a polycytidylic acid product (16). A recombination 
reaction performed by Lehman (85) and a polymerization reaction by Burke (83, 84) 
show an ωG in the ribozyme catalyzing a nucleophilic attack similar to the first step of 
the TIS reaction.  In the recombination reaction, the substrates AB and CD form CB and 
AD (85), but do not continue polymerizing because there is no ωG on the resultant 
products.  In the polymerization reaction, the substrate AB can form ABB, ABBB, and 
A(B)n (84) because the 3’-G on the end of B allows it to mimic the 3’-end of the 
ribozyme.  The TIS reaction occurs in part because one substrate has a 3’-G (ωGi on the 
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insert) and one does not (starting material).  This setup allows for insertion, but not a 
repeating polymerization reaction.  
   
Implications: Mechanism 
The TIS reaction is a new group I intron-derived ribozyme reaction, and it 
demonstrates unexpected molecular recognition interactions between the P. carinii group 
I intron-derived ribozyme and its RNA substrates.  There is an added complexity in the 
TIS reaction compared to other group I intron-derived ribozyme reactions, since the TIS 
mechanism is dependent on the ribozyme binding two different substrates and forming 
the P1 helix twice (called P1 and P1i).  Therefore, a crucial conformational shift must 
occur between the first and second reaction steps (Figure 5.7, between 2a and 3a) to 
disrupt the first P1i helix (formed with the 9mer insert) and allow formation of the second 
P1 helix (formed with the 12mer starting material).  Each substrate can base pair with six 
nucleotides of the ribozyme’s IGS, suggesting that the relative binding strength of the 
substrates is critical for allowing the correct mechanism to occur.  Another added 
complexity to this reaction is that the GBS appears to be used three different times in the 
reaction; binding ωG from the ribozyme for the first step, ωGi from the insert for the 
second step, and the ωG from the ribozyme again for the third step.   
The P. carinii ribozyme recognizes two TIS substrates; initially and primarily 
through base pairing.  In addition, it is suspected that the recognition elements of the 
ribozyme can be changed to target other substrates, as seen with the P. carinii ribozyme 
in the TES reaction (6).  If the P1i helix is too strong compared to the P1 helix, however, 
the starting material might not be able to compete off the insert from the IGS of the 
ribozyme.  This would essentially stop the reaction after the first step.  Conversely, if the 
P1 helix is too strong, it might preferentially bind first and inhibit formation of P1i, 
leading to the pathway in Figure 5.7, 2b.  Apparently, the balance between formation of 
the two P1 helices may make targeting the TIS reaction to different substrates more 
complex compared to simpler group I intron-derived ribozyme reactions.  Nevertheless, 
our mechanism does not preclude retargeting these ribozymes. 
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Implications: Potential Applications 
The TIS reaction could potentially be useful as a biochemical tool, for example to 
insert a sequence, perhaps even one containing a modified nucleotide or a marker, into a 
large RNA transcript.  Large RNA transcripts are typically made in vitro by T7 run-off 
transcription, so adding site specific modifications is very arduous (91).  Using the TIS 
reaction, a small RNA insert could be synthesized (perhaps with a desired modification), 
targeted to an exact location, and inserted into a large transcript.  The TIS reaction could 
also be used as an RNA repair agent.  Deletion and frame shift mutations could 
potentially be repaired by insertion of an RNA sequence at a specific location.  The need 
for the ribozyme to bind two separate substrates, however, is an anticipated complication 
for the TIS reaction in vivo.  This can easily be overcome, fortunately, by using the TIS 
ribozyme with the first intermediate already attached, as seen in step 3a of Figure 5.7.  
This particular reaction does work (Figure 5.8, lane F), requires one substrate (instead of 
two), and proceeds through only two reaction steps (instead of three).   
 
Implications: Cellular Function 
The ability of group I intron-derived ribozymes to catalyze the TIS reaction also 
has implications for potential function of the intron once it splices out of its transcript in 
the cell.  Since both TES and TIS ribozymes are largely unaltered from spliced introns, 
we speculate that at one point in evolution (and perhaps even today), introns could be 
shuffling RNA information by the TIS and TES reactions.  Indeed, we have recently 
shown that the TES reaction can occur in an artificial system in vivo by delivering a TES 
ribozyme into a prokaryotic cell (92).   
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 Ribozyme          3’-End Sequence
rPC ~~~~CUAG
rPC-ωA ~~~~CUAA
rPC-1 ~~~~UGUG
rPC-3 ~~~~CUAGCUCGUG
rPC-3ωA ~~~~CUAACUCGUG
rPC-4 ~~~~CUAGCUCGUGAAACAU
Starting 
Material           Sequence
12mer AUGACUAAACAU
12mer-dU AUGACdUAAACAU
6mer AUGACU
6mer-dU AUGACdU
Insert Sequence
9mer GCUCUCGUG
9mer-dU GCdUCUCGUG
9mer-ωAi GCUCUCGUA
7mer-minus-3’UG       GCUCUCG_ _
7mer-minus-5’GC        _ _UCUCGUG
Table 5.1. Ribozyme, starting material, and 
insert sequences.
The sequences highlighted by gray boxes indicate 
the substrates and ribozyme used in the standard 
TIS reaction.  The bold and underlined nucleotides 
indicate the positions that differ from the standard 
reaction components.  Note that rPC-3, rPC-3ωA, 
and rPC-4 are the intermediate ribozymes with part 
of the starting material and insert attached to the 
3’-end.  The symbol “~~~~” represents the 5’-end 
of the ribozyme that is the same for all the 
ribozymes tested.  The complete ribozyme 
sequence is shown in Figure 5.2. 
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 TES Starting Material 36mer
TES Product
16mer
Excised Region
20mer
A Trans Excision-Splicing
TIS Starting Material
12mer
TIS Insert
9mer
TIS Product
18mer
3mer
B Trans Insertion-Splicing
 
Figure 5.1. The trans excision-splicing reaction and trans insertion-splicing reaction. A) 
The 36mer TES starting material reacts with ribozyme rPC to give the 16mer TES 
product and 20mer excised region.  B) The 12mer starting material and 9mer insert react 
with ribozyme rPC to give the 18mer TIS product.   
 
 96 
 G
A
A
A
G
C
G
G
C
G
U
GA AA
A
C
G
U
UA
G
C
U
A
G
U
G
A
U
C
U
G
G
A
A
U A A
A
U
U
C
A
G
A
U
U
G
C
G
A
C
A
C
U
G
U
C
A
AA
U
U
G
C
G
G
G
G
A
A
G
C
C
C
U
A
A
AG
A
U
U
C
A
A
C
U
A
C
U
A
A
G
C
A
G
U
U
U
G
U
G
G
AA
A
C
A
C
A
G
C
U
G
UG
GCCGAGUU
A
A
U A G C
C C
UG G
G U A U
A
G
UA
A
C
AA
U
G
U
U
G
A
A
U
A U
G
A
A
U
C
U
U
U
U
A
G
A
U
G
A
A A U
G
G
G
U
G
A
U
C
C
G
C
A
G
C
C
A
A
G
U
C
C
U
A
A
G
G
G
C
A
U
U U
U
U
G
U
C
U
A
U
G
G
A
U
G
C
A
G
U
U
C A
ACG
A
C
U
G
A
U
G
G
C
A
G
U
G
G
G
U
A
U
U
G
U
A
A
G
G
A
A
U
U
GA
G
U
U
U
U
C
U
U
G
C
A
G
U
G
C
U
U
A
A
G
G
U
A
U
A
G
U
C
U
G
C
C
P5b
P5c
P5a P5
P4
P6
P6b
P6a
P2.1
P2
P8
P3
P7
P9
A
G
U
G5'
G
G
C
A
U
3'
A
U
U
A
U
A
U
G
50
100
150
200
250
300
A
u
a
c
c
u CUCUUUCG
A
A
A G A A AG A G
C
GAUC
rPC
IG
S
 
 
Figure 5.2. Proposed secondary structure of a P. carinii group I intron-derived ribozyme 
(rPC).   
 97 
Ribozyme 
Intermediate
9mer
12mer
18mer
6mer
A B  C D E F G H  I J  K LM N O 
3mer
Size controls
 
Figure 5.3.  Proof for the first nucleophilic attack in the TIS reaction.  Polyacrylamide gel 
showing reactants and products of the TIS reaction using 200 nM ribozyme, 1 μM insert, 
1 nM starting material, and 10 mM MgCl2 run for 2 h at 44oC.  Lanes E and I contain 5’-
end radiolabeled 6mer, 9mer, 12mer, and 18mer (sequences in Table 5.1) run as a size 
control.  Lane L contains 3’-end radiolabeled 9mer run as a size control.  Lanes A and B 
contain the standard TIS reaction run with 5’-end radiolabeled 12mer (lane A) and 3’-end 
radiolabeled 12mer (lane B).  The rest of the lanes are described in the text. 
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Figure 5.4. Sequencing of 5’-end radiolabeled TIS product.  The 18mer TIS product was 
isolated from a large reaction of rPC, 9mer insert, and 5’-end radiolabeled 12mer.  Both 
synthetic 18mer product and isolated 18mer TIS product were enzymatically sequenced 
next to each other using U2, CL-3, T1, and B. cer. endonucleases.  The dotted line shows 
the position of the inserted region (CUCGUG) between the 5’ and 3’-ends of the 12mer 
starting material.  Nuclease U2 is specific for adenosine, CL-3 for primarily cytidine, T1 
for guanosine, and B. cer. for primarily cytidine and uridine. Note that the intensity of the 
bands in the boxed regions was enhanced relative to the rest of the gel for easier 
visualization. 
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Figure 5.5. TIS optimization graphs.  Except for the changing variable, TIS reactions 
were run under the optimum reaction conditions of 200 nM ribozyme (rPC), 1 μM insert 
(9mer), 1 nM 5’-end radiolabeled starting material (12mer), and 10 mM MgCl2 for 2 h at 
44oC.  The standard deviations for the data in each graph were typically under ten 
percent.   
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Figure 5.6. A representative time study gel and observed rate constants for the TIS 
reaction.  The polyacrylamide gel shows reactants and products of the TIS reaction using 
200 nM ribozyme (rPC), 1 μM insert (9mer), 1 nM 5’-end radiolabeled starting material 
(12mer), and 10 mM MgCl2 run over 3 h at 44oC.  The graph shows the average amount 
of 18mer TIS product formed over time for reactions run with 6, 10, 14, and 18 mM 
MgCl2.     
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 Figure 5.7. Proposed mechanism for the trans insertion-splicing reaction.  The rPC 
ribozyme is represented by black lines and the IGS sequence and ωG are shown.  1) The 
rPC ribozyme binds the 9mer insert (pathway “a”).  Alternatively, the 12mer starting 
material (pathway “b”) can bind the ribozyme to give dead-end products.  2a) The insert 
(in black and green) forms a P1i helix with the IGS of the ribozyme.  The ωG of the 
ribozyme attacks at the 5’-splice site in the 9mer insert.  3a) The 12mer (in pink and blue) 
displaces the insert fragments from P1i and forms a second P1 helix.  A nucleophilic 
attack by the ωGi on the insert (attached to the ribozyme) occurs at the 5’-splice site in 
the 12mer starting material. 4a) A nucleophilic attack of the 3’-U from the 5’-half of the 
starting material (in pink) at the ωG in the ribozyme produces the 18mer TIS product 
(inserted region in green between the pink and blue halves of the 12mer starting 
material).  2b) This alternative pathway involves the 12mer starting material forming the 
P1 helix first.  The ωG on the ribozyme can attack at the 5’-splice site in the 12mer, 
leading to 6mer product (in pink) and the 3’-half of the 12mer attached to the ribozyme 
(in blue).  
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Figure 5.8. Proof for the second and third nucleophilic attacks in the TIS reaction.  
Polyacrylamide gel showing reactants and products of the TIS reaction using 200 nM 
ribozyme, 1 μM insert, 1 nM starting material, and 10 mM MgCl2 run for 2 h at 44oC.  
Lanes E, I, and L contain 5’-end radiolabeled 6mer, 9mer, 12mer, and 13mer (sequences 
in Table 5.1) run as a size control.  Note that reactions in lanes F, G, H, J, K, M, N, and O 
did not contain insert since the insert sequence was attached to the ribozyme 
intermediate.  Lanes A and B contain the standard TIS reaction run with 5’-end 
radiolabeled 12mer (lane A) and 3’-end radiolabeled 12mer (lane B).  The rest of the 
lanes are described in the text. 
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Figure 5.9. Secondary structure at the 3’-end of the rPC-1 and rPC ribozymes.  The rPC-1 
ribozyme is the exact sequence of the P. carinii group I intron, capable of forming a P9.0 
helix.  The P9.0 helix positions the ωG on the ribozyme into the G binding site in the 
ribozyme.  The rPC ribozyme used in the TIS reaction differs from rPC-1 by three 
nucleotides and cannot form a P9.0 helix. 
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CHAPTER SIX - Conclusions 
 
 The ability of group I introns to splice out of RNA transcripts depends on 
molecular recognition interactions of the 5’ and 3’-exons in the catalytic core, which 
helps position the exons for catalysis.  Likewise, ribozymes derived from these group I 
introns also depend on molecular recognition of their substrates to perform catalytic 
reactions.  These ribozymes no longer have their exons attached, so their substrates are 
exogenous.  Presumably, the molecular recognition interactions of these exogenous 
substrates with the ribozyme are even more critical for correct positioning and subsequent 
catalysis. 
 Three separate studies were performed for this dissertation work.  Four different 
ribozyme reactions were evaluated, one of which (the TIS reaction) was newly 
discovered and its mechanism elucidated.  In general, these studies have shown that the 
molecular recognition interactions between the P. carinii ribozyme and its substrates are 
more complex than previously thought.   
 
Molecular Recognition in the Suicide Inhibition and Reverse Cyclization Reactions 
The combinatorial assay described in Chapter Three has proven useful for gaining 
a more fundamental understanding of the molecular recognition properties of P. carinii 
IGS-mediated reactions.  We used the combinatorial data to assess what sequences could 
bind the IGS and react in either the reverse cyclization or suicide inhibition reactions 
(Figure 3.1).  As expected, the native 5’ exon sequence occurred most often for both the 
reverse cyclization and suicide inhibition reactions, although the fidelity for the two 
reactions differed (58% for the reverse cyclization reaction and 13% for the suicide 
inhibition reaction, each at 15 mM MgCl2). Apparently, the molecular recognition 
interactions of the IGS and 5’ exon mimics in the reverse cyclization and suicide 
inhibition reactions are different, indicating a dynamic use of the IGS between the two 
reactions.   
The combinatorial results in general show that the amount of non-pairing 
mismatches increases farther away from the 5’-splice site, suggesting the sequence 
specificity of these P. carinii group I intron reactions is not that high. In addition, the 
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strength of overall binding of the exon to the ribozyme can change considerably simply 
by changing the specific base paired-sequence of the P1 helix.  Even though the 5’ exon-
IGS helices are complementary, the ribozyme likely forms tertiary interactions with only 
specific base pairs at certain P1 helix positions. 
 
Molecular Recognition in the TES Reaction 
The Tetrahymena ribozyme can perform the TES reaction (Figure 4.1), suggesting 
that the TES reaction might be a general group I intron-derived ribozyme reaction.  The 
native P. carinii ribozyme is much more effective at the TES reaction than the 
Tetrahymena ribozyme.  Since the first step of the TES reaction involves ribozyme-
mediate 5’-splice site cleavage by a hydroxyl from the buffer, the P. carinii ribozyme’s 
ability to perform the TES reaction so well appears to be related to its enhanced ability to 
catalyze this reaction.  
The hybrid P. carinii ribozyme with the Tetrahymena IGS has substantially 
decreased observed rate constants and TES product yields compared to the native P. 
carinii ribozyme.  Apparently, changing the IGS to a different, yet complementary 
sequence, decreases the yield and rate of reaction.  In addition, the native substrate 
sequence for the P. carinii intron appears to form critical tertiary interactions with the P. 
carinii ribozyme.  This suggests that the P. carinii intron (and presumably other group I 
introns) have evolved to specifically recognize its native substrate sequence through 
complex molecular recognition interactions.     
 
Molecular Recognition in the TIS Reaction 
 We report that a P. carinii ribozyme can insert one RNA substrate into another 
(the trans insertion-splicing reaction), and all evidence suggests that there are three 
reaction steps to the 18mer TIS product (Figure 5.7).  The TIS reaction involves 
interesting molecular recognition interactions between a P. carinii group I intron and its 
RNA substrates.  The TIS mechanism is dependent on the ribozyme binding two different 
substrates and forming the P1 helix twice (P1 and P1i).  This duel use of the P1 helix 
gives added complexity in the TIS reaction compared to other group I intron-derived 
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ribozyme reactions (5, 6), and suggests that the relative binding strength of the substrates 
may be critical for allowing the correct TIS mechanism to occur.  Since the TIS reaction 
is more complex, it may be more challenging to retarget the TIS reaction to a different 
sequence (although not impossible), compared to the TES reaction. 
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